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Abstract:
A variety of parasites persist in their host through sequential expression of variant surface
antigens. Intriguingly, the genes encoding these antigens are frequently found adjacent to
the telomeres. Telomeres are nucleoprotein complexes consisting of tandem DNA repeats
and proteins that bind to them. Their function is to protect chromosome ends from the
DNA repair machinery that would otherwise recognize them as double-stranded breaks.
With the help of the ribonucleoprotein telomerase they compensate for the gradual
sequence loss that would otherwise arise from the inability of conventional DNA
polymerases to replicate chromosome ends.
In Trypanosoma brucei, the causative agent of African trypanosomiasis, the surface coat
consists of a dense layer of Variant Surface Glycoproteins (VSG). The actively
transcribed VSG is found in one of ~20 telomeric Expression Sites (ES). Antigenic
variation can occur by transcriptional switching, reciprocal translocations, or duplicative
gene conversion events between ES. In recent African isolates, duplicative gene
conversion occurs at a high frequency and predominates, but the switching frequency
decreases dramatically upon laboratory-adaptation. Very little is known about the
regulation of antigenic variation.
To address whether telomeres are involved in antigenic switching we created telomerasedeficient T. brucei. Telomerase-deficient parasites exhibited progressive telomere
shortening at a rate of 3–6 bp/PD, which correlates with the end replication problem and
G-overhang length. Upon reaching a critical length, short silent ES telomeres stabilized.
Telomere decline was accompanied by loss of minichromosomes and rearrangements at
intermediate chromosomes. Essential megabase chromosomes remained stable.

After extensive telomere attrition, the active ES telomere stabilized, but the transcribed
VSG was gradually lost from the population and replaced by a new VSG through
duplicative gene conversion. We present a model in which subtelomeric break-induced
replication-mediated repair at a short ES telomere leads to duplicative gene conversion
and expression of a new VSG.
By restoring telomerase, we studied telomere elongation dynamics. At the active ES, the
rate of telomere elongation is inversely proportional to the initial telomere length. At
silent ES, the rate of elongation remains constant. We propose a model where
transcription-dependent

chromatin

remodeling

permits

telomere

elongation

by

telomerase. We show that telomere growth at a rate of 6–8 bp/PD appears to be a unique
feature of T. brucei.
Lastly we demonstrate that fast-switching African T. brucei isolates have dramatically
shorter telomeres than laboratory strains. We present a speculative model in which
telomere growth and breakage affect the rate of antigenic switching.

To Willy and Dorly Kühnis-Schöb
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Chapter I
Historical perspective of African sleeping sickness and Trypanosoma brucei

African Sleeping Sickness is caused by the protozoan parasite Trypanosoma brucei
and kills ~100,000 people per year. Roughly 60 million people live in diseaseendemic areas (1,2). Studies on Sleeping sickness commenced in the late 18th century
by Captain Sir David Bruce of the British army. Bruce was born in Melbourne,
Australia in 1855, trained as a bacteriologist with Robert Koch in Berlin and became
a resident medical officer in Malta. In 1883, he devoted his skills to the study of
Malta fever, an infection that was widespread around the Mediterranean (3). Within a
few years, he succeeded in isolating the causative agent, a gram-negative, non-motile
bacteria named brucella, from deceased patients. By culturing and infection of
laboratory animals, Bruce proved that brucella is the causative agent of Malta fever.
In 1894, to his bitter disappointment, Bruce was relocated to Pietermaritzburg in
Zululand. His goal was to investigate a mysterious disease that the locals called
“nagana”=“loss of spirit” in ravaged cattle. After a several week journey into fly land,
Bruce set up his one-man laboratory in a mud-hut on top of Umbombo hill. The
laboratory was 2,000 feet above sea level and free of flies, which proved very helpful
to Bruce’s investigation.
First, Bruce noted the appearance of a “Haematozoa” in the blood of infected cows.
Secondly, he observed that healthy cows, taken into the low country, developed the
disease as did the two dogs that accompanied Bruce on his daily excursions. Upon
inspection of their blood, Bruce discovered roughly 20 µm slender, flagellated
parasites that “wriggle madly like little snakes”. Healthy cattle fed on herbage from
fly-infested lower country remained fit, putting in doubt earlier suspicions that the
parasite was transmitted through infected feed. He then mapped the prevalence of
infected and non-infected animals to confined geographic locations. The former were
found predominantly in fly-infested bush and scrub country, whereas the latter lived
in open areas with less vegetation. This finding led him to his pioneering study of the
tsetse. He demonstrated that, an hour after feeding on infected cattle, a few “alive and
kicking haematozoa” were present in the tsetse stomach. Tsetse that fed on infected
1

game animals transmitted the parasite to healthy animals, which subsequently became
sick. He fulfilled Koch’s postulates when he successfully infected a dog with blood
from an infected antelope. Bruce demonstrated for the first time that an insect can
transmit a protozoan parasite from a sick to a healthy animal. In humans the parasite
causes sleeping sickness, an infection that can last from weeks to years and is fatal.
During early stages of an infection, the parasite is found predominately in blood,
lymph and peripheral organs. At later stages, the parasite crosses the blood-brain
barrier and causes neurological disorders, including disruption of the circadian
rhythm and loss of orientation, symptoms that gave the disease its notoriety and
name. It remains unclear what prompts this parasite to cross the blood-brain barrier.
T. brucei gambiense is prevalent in central and western parts of Africa where it
causes chronic infections. In eastern and southern areas, T. brucei rhodesiense causes
more acute infections.
How does the parasite maintain its presence in the bloodstream of its mammalian host
and successfully evade the immune response? The first clue to this puzzle came from
the work of Sir Ronald Ross, who won the Nobel Prize in 1902 for proving that the
anopheles mosquito is the transmitting vector of the malaria parasite, Plasmodium
falciparum. Ross studied the parasitemia in the bloodstream of a patient in Zimbabwe
during the course of an infection. He observed that the number of parasites in the
bloodstream fluctuated dramatically; waves of parasitemia followed one another, until
the patient died. He correctly speculated that the parasite might evade the immune
response by frequently changing its surface (Ross and Thomson, 1910).

The variant surface glycoprotein surface coat

The first glimpse of the parasite surface was provided in the late 1960’s (4). Electron
microscopy revealed that the surface of the parasite is coated with a dense protein
layer consisting of Variant Surface Glycoproteins (VSG) (Figure 1A) (5).
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Figure 1
T. brucei, its surface coat and VSG Expression Sites (ES)
A) Upper panel: Scanning Electron Micrograph (EM) of bloodstream form T. brucei.
Lower panel: EM cross section. ~107 Variant Surface Glycoproteins (VSG) form a
dense, homogeneous surface coat.
B) T. brucei chromosomes, separated by Pulsed-Field Gel Electrophoresis (PFGE)
and visualized by hybridization with a (TTAGGG)4 probe. Under these conditions,
11 Megabase Chromosomes (MBC) and 5-7 Intermediate Chromosomes (IC) are
well separated, whereas ~100 Minichromosomes (MC) are concentrated at the bottom
of the gel.
C) Characteristic features of T. brucei VSG Expression Sites (ES): ES are located at
the physical ends of chromosomes, flanked by telomeric TTAGGG-repeats. The
upstream boundary of an ES consists of 50 bp repeat arrays. Transcription is initiated
at the ES promoter. Each ES contains Expression Site Associated Genes (ESAGs).

Subsequent experiments suggested that the surface coat consisted of a homogenous
layer of ~107 VSG molecules, thus, different waves of parasitemia represented
different VSG (6). This work, for the first time, confirmed Ronald Ross’ notion that
the parasite evades the host immune response by sequential expression of different
surface epitopes, a process known as antigenic variation.

Characterization of VSG proteins

Throughout the late 70’s and 80’s, VSG proteins were characterized in great detail,
and 2.9Angstrom X-ray crystal structures exists for the N-terminal domains of two
VSGs (5-7). VSGs range in size from 433 to 470 amino acids with a molecular mass
of roughly 60–70 kDa. The rod-like VSG molecule contains two characteristic alphahelices of ~70 A and the top of the molecule is formed by the ends of both helices and
consists of three-stranded beta-sheets. VSG are inserted into the cell surface lipid
bilayer via attachment of a glycosylphatidylinositol- (GPI) anchor (8,9). The notion
that VSG are densely packed on the parasites surface came from the observation that
monoclonal antibodies raised against purified VSG molecules could not be used on
living trypansosomes. Thus, in a densely packed coat of rod shaped VSG molecules,
most of the VSG molecule is inaccessible to the antibody whereas the top is exposed
(10). The X-ray structure of VSG supports this notion.
In the early 1980’s, it was estimated that the genome of T. brucei contains roughly
1,000 VSG genes, but only one is expressed at a given time (11). Most VSG genes lie
in large arrays within the subtelomeric region, a location that is known to be a hotspot
for ectopic recombination. This might ensure that VSG participate in recombination
events, which increases antigenic diversity and prevents herd immunity (12).

The genome of T. brucei

The ~35 Mb genome of T. brucei consists of 11 large diploid megabase chromosomes
(MBC) that range in size from 1–5.2 Mb, several intermediate chromosomes (IC)
4

(200–700 kB) and ~100 minichromosomes (MC) (25–150 kB) that can be readily
separated by Pulsed Field Gel Electrophoresis (PFGE) (Figure 1B) (13-15).
Hybridization studies and the recent sequencing of the T. brucei genome
demonstrated that MBC contain housekeeping genes and a majority of V S G
Expression Sites (ES). Homologous MBC pairs can differ in size up to 15%, which
has been suggested to be due to repetitive sequences (16). There are ~5–7 IC that
appear to contain ES and little else, and ~100 MC that mainly consist of 177-bp
tandem repeats, silent VSG genes and telomeres (15,17,18). MC are thought to
provide a reservoir of VSG genes that can be activated by duplicative transposition.
Despite their similarity and number, MC are mitotically stable and faithfully
segregate during several years of continuous propagation (19,20).

The architecture of telomeric VSG expression sites

The first clues as to how the parasite can exclusively express one VSG were provided
in 1982, when it was shown that the actively expressed VSG is susceptible to
digestion with the exonuclease Bal 31. This result demonstrated that the VSG is
located in an Expression Site (ES) close to the chromosome end (21). Hybridization
studies, using sequences upstream of the VSG, suggested that there might be ~14–25
conserved ES containing different VSGs (22). Subsequent work from several
laboratories established that there are ~20 telomeric ES (23,24). ES are ~50 kB long
polycistronic transcription units that are flanked by 50-bp repeats and the telomeres
(25) (Figure 1C). With the exception of RsaI, these 50-bp repeats are devoid of
restriction enzyme recognition sites and present in long arrays on MBC and IC (26).
It remains unknown whether 50-bp repeats play any role in ES regulation, however,
this topic is under investigation in our laboratory (L. Figueiredo, personal
communication).
Downstream of the ES promoter are at least 8 conserved Expression Site Associated
Genes (ESAGs) (Figure 1C) (22,25,27). The function of most ESAGs remains unclear,
notably ESAG 1, a membrane associated glycosylated protein, ESAG 2 and 3, which
have putative transmembrane domains, and ESAG 5 (28). More is known about
5

ESAG 4, a membrane-associated adenylate cyclase, ESAG 8, an RNA binding
protein, and ESAG 10 which is not present in all ES, but could encode a putative
Biopterin transporter (29-32). ESAG 6 and 7 form a heterodimeric transferrin
receptor and localize to the flagellar pocket (33,34). ESAG 6 and 7 show slight
sequence divergence between different ES, and it has been suggested that usage of
different ES could optimize transferrin uptake from the serum of different mammals
(28,35-37). The VSG is located ~50 kB downstream of the ES promoter and is
flanked by imperfect 70-bp repeats and hexameric TTAGGG-repeats.

Monoallelic transcription of VSG ES

As mentioned above, with the exception of the VSG gene and the slight sequence
variation among ESAGs, ES share the same DNA elements. However, the cell is
capable of fully transcribing one of ~20 ES in a mutually exclusive fashion.
Monoallelic transcription of a particular gene family is not unique to trypanosomes
and has been described in several organisms. Smell is perceived by olfactory neurons,
which interact with particular odorant molecules in the nasal cavity (38). Each neuron
exclusively expresses one of ~1,000 G-protein-coupled olfactory receptors, which
interacts with one odorant molecule and transmits the signal into the olfactory bulb
(glomeruli) (39). Two main models have been discussed. First, a unique regulatory
sequence upstream of the expressed receptor gene promoter could recruit the
transcription machinery. Second, a transcription factor, only present in a privileged
subnuclear compartment could limit expression to one gene. Alternatively, this factor
could be present in limiting amounts, thus ensuring exclusivity (40). I want to
highlight some similarities and differences between the two systems: VSG genes are
transcribed from a telomeric ES, whereas olfactory receptor genes are not. A second
VSG gene can be inserted in tandem in the active ES locus, resulting in parasites with
a mixed surface coat (41). Olfactory neurons express only one gene, even if multiple
copies are integrated in tandem arrays (42). The region around the promoter is
conserved in all T. brucei ES and no particular regulatory element has been found in
olfactory receptor genes.
6

Below, several mechanisms that could ensure transcription of a single VSG in T.
brucei are discussed. It is possible that these mechanisms work in conjunction and
add additional layers of regulation to ensure monoallaelic transcription.

Telomere position effect

In 1990 it was shown that subtelomeric regions of yeast chromosomes are subject to
transcriptional repression: a Telomere Position Effect (TPE) (43). At some yeast
chromosome ends, this repression spreads from the telomere towards the centromere
and is dependent on telomere-associated factors such as Sir 2/3/4 and the Ku70/80
heterodimer (44-46). At native telomeres, silencing varies among chromosome ends
and is more pronounced at confined subtelomeric region such as the core X element
(47,48). TPE also exists also in T. brucei. A neomycin cassette under the control of an
rDNA or ES promoter was inserted at different locations along a silent ES. Similarly
to yeast, levels of transcriptional repression increased when the cassette was moved
towards the telomeres (49). A recent result demonstrated that transcriptional
repression is increased when the reporter gene was placed in the context of an ES
rather than located at a short seeded telomere at the rDNA locus (50). Unfortunately,
the precise genomic location of the seeded telomere was not determined in these
clones. The telomere was seeded onto a broken chromosome and it is conceivable that
this chromosome end was not properly sequestered into a cluster where silencing
factors might be present. It was concluded that telomeres mediate repression
independent of ES context, but additional repression operates within VSG ES (50).
In yeast, transcriptional repression extends ~5 kB towards the centromere; in T.
brucei, the ES promoter is located ~50 kB away from the telomere, and it is unclear
whether TPE is responsible for transcriptional attenuation of the ES promoter (24).
Furthermore, T. brucei homologues of the KU70/80 heterodimer and SIR2, proteins
implicated in yeast TPE, do not play any role in ES silencing in T. brucei (51) (Hoek
and Cross, unpublished results).
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Expression site body

It has been suggested that monoallelic transcription could be achieved by
sequestering one ES into a subnuclear compartment that would provide essential
transcription elongation factors (52).
Transcription at all ~20 ES promoters is mediated by α-amanitin resistant RNA
polymerase I (53,54). At 19 silent ES, transcription ceases ~600–700 bp downstream
of the promoter (24,55). In general, POL I mediated transcription is restricted to the
nucleolus, where it transcribes rDNA genes. By in situ hybridization, active ES
transcripts were found at a distinct locus outside the nucleolus, suggesting that full ES
transcription might occur in a special nuclear subcompartment (52).
Further evidence to support this hypothesis was provided by raising monoclonal
antibodies against the large subunit of RNA POL I. Furthermore the active ES was
tagged with 256 tandem copies of the lac operator sequence in a strain that contained
a tetracycline-inducible GFP-LacI fusion protein. By immuno-fluorescence
microscopy, the GFP-LacI co-localized with POL I signal to a confined spot outside
the nucleolus: the Expression Site Body (ESB). Taken together, these results suggest
that monoallelic transcription could be achieved by sequestering the actively
transcribed ES into a distinct subnuclear compartment, called the ESB (56). It
remains to be determined whether this privileged compartment facilitates full ES
transcription by providing factors essential for transcriptional elongation.

J-base DNA modification

During restriction mapping of various ES, it was shown that PstI and PvuII (and
sometimes HindIII and SphI) restriction endonucleases only partially cleave in silent
ES. It was suggested that this could be the consequence of a DNA modification that
mediates silencing of ES (57,58) By hydrolysis of nuclear DNA, 32P-postlabelling and
two-dimensional thin layer chromatography (2D-TLC) experiments, a novel DNA
base called β-D-glucosyl (hydroxymethyl) uracil was identified (59). This base,
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called J, consists of a glycosylated thymine and is unique to kinetoplastid protozoan
parasites. J-base is enriched in the repetitive sequences that flank every ES: the
upstream 50-bp repeats and the downstream telomeres (60). Enrichment was
independent of the transcriptional status of the ES. However, J is absent from the
active ES, whereas in silent ES, J concentration increases closer to the telomeres.
J biosynthesis is likely to occur in two steps, involving a thymine-hydroxylase (TH)
and a glucosyl-transferase (GH). The genes encoding these proteins remain to be
identified. More is known about J-binding proteins (JBP1 and JBP2) (61,62). Recent
work suggested that JBP2, a SWI2/SNF2-like ATPase, remodels chromatin and
makes DNA accessible to TH and GH. JBP1 then binds, maintains and propagates the
modification along the DNA (62). J is also present in protozoa that do not undergo
antigenic variation and a possible connection between J and ES silencing in T. brucei
remains speculative.

Chromatin structure

Early studies demonstrated that the actively expressed VSG gene is sensitive to
DNase I and single-stranded endonuclease digestion (63,64). This hypersensitivity is
possibly a consequence of the heavy transcription that occurs in the active ES locus.
Hypersensitivity to DNase treatments is often indicative of cis-acting regulatory DNA
elements (65). To test whether such elements are present in active or silent ES, a
neomycin luciferase marker cassette was inserted downstream of the ES promoter
(55). Cells were permeabilized and treated with increasing concentrations of
micrococcal nuclease. The DNA was isolated and digested with BamHI, which
produced a 50 kB fragment containing the neo gene at the 3´ end. By southern
blotting using the neomycin marker gene as a hybridization probe, two hypersensitive
regions were identified: one was in the core of the promoter and the other ~600 bp
upstream. However, no difference was found between active and silent ES, providing
further support to the idea that the transcription machinery is present at both silent
and active ES promoter (24,55).
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Molecular mechanisms of antigenic switching

To evade the host immune response and maintain an infection, parasites must
sequentially express a large repertoire of VSG. Switching of the surface coat gives
rise to new variants that survive eradication by the host immune response and
dominate in a successive wave of parasitemia. In the past 25 years, the molecular
mechanisms underlying antigenic switching in T. brucei have been elucidated in some
detail (Figure 2). Many antigenic switches occur concomitantly with a genomic
rearrangement, such as a duplicative gene conversion (66,67). Two pieces of evidence
linked the duplicated VSG copy to the active ES: the appearance of a duplicated band
correlated with the presence of its corresponding mRNA and the duplicated copy was
more sensitive to DNase digestion, suggesting a more accessible open chromatin
structure (68,69). In conclusion, the duplicated copy of a silent VSG can replace the
transcribed VSG in an actively transcribed ES (Figure 2A) (68).
Secondly, reciprocal translocations, often encompassing large parts of two ES, can
lead to activation of a new VSG (70-72) (Figure 2B). Depending on which strands are
cleaved during Holliday junction resolution, reciprocal and non-reciprocal
(duplicative) translocations can originate from the same recombination intermediate.
Thirdly, simultaneous inactivation / activation of transcription at two ES results in an
in situ switch and expression of a new VSG (Figure 2C) (72). In the context of the
proposed ESB, one ES could simply replace another in this privileged compartment.
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Figure 2
Molecular mechanisms underlying antigenic variation
A) Duplicative gene conversion of a silent VSG into the transcribed ES
B) Telomere exchange: reciprocal translocation between silent and active ES
C) Transcriptional switching between two ES

It remains heavily debated which of the three mechanisms dominates or is most
relevant to wild-type trypanosomes. Arguably the most extensive analysis to address
this question comes from David Barry’s lab (73). This study established that in
pleomorphic wild-type isolates, 10 out of 11 antigenic switches occurred through
duplicative gene conversion (Figure 2A). Although the number of analyzed clones
might limit the interpretability of this result, it is the most extensive study that
analyzed switching in a “wild-type” setting.

Methods to measure antigenic variation

Perhaps the most pressing question in trypanosome biology in the past several years
is what regulates the frequency of antigenic variation. This question remains largely
unanswered, in part because of experimental difficulties to efficiently measure the
VSG switching rates. Essentially all available methods aim to selectively kill
parasites expressing a particular VSG in a clonal population. Several methods have
been developed to achieve this.
First, laboratory mice can be immunized by exposure to a particular VSG. This can be
achieved by infecting the mouse with a sub-lethal number of parasites expressing a
particular VSG or by injection of purified VSG protein (74). Subsequently,
vaccinated mice are challenged with a clonal population of parasites expressing the
VSG used for immunization. The immune system selectively kills all parasites that
have not undergone an antigenic switch and switchers can be outgrown in mice or in
vitro (70,75). From the number of infected mice, the frequency of switching can be
deduced.
Secondly, negative selection against a particular VSG can be achieved by in vitro
complement-mediated immuno-lysis, using a specific antibody against the expressed
VSG (75-78). Nevertheless, parasites that aggregate in clumps can survive this
treatment and give rise to false positives (79). In both cases, the procedure is
laborious and difficult, requiring numerous repetitions to achieve statistical
significance.
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A third negative selection procedure is to place the thymidine kinase thymidylate
kinase (TK) gene from the herpes simplex virus (HSV-1) downstream of the promoter
of the active ES. TK phosphorylates nucleoside analogs that can be added to the
culture medium and kill cells by competitive inhibition of DNA polymerase (78,80).
Thus, addition of nucleoside analogs selects for parasites that have switched off the
ES that contains the TK gene. Although activation of another ES occurred, in 70% of
switching events studied, this selection procedure led to an aberrant loss of the TK
gene and the active ES (and in most cases the 50-bp repeat arrays). The minority
(18%) of switched parasites had activated another ES by in situ switching. Since the
switching frequency in these parasites was relatively high (10-5/ cell division) the
authors argued that inactivation of the active ES is an essential step for the activation
of another (78). Regardless, the relevance of these findings is questionable since such
aberrant switching events have not been observed in nature.
A recent report employed RNAi against the actively transcribed VSG to select for
switched parasites (81). Although in principal a very elegant idea, the reported
switching frequency was dramatically higher than anticipated (10-4 / division). Several
groups, using different techniques consistently obtained much lower switching rates
for the same strain (10-6–10-7 / division) (74-76,82). These discrepancies should be
resolved before this method can be used.
Positive selection for switched parasites can be achieved by insertion of a drug
resistance marker into a silent ES (82). Subsequent exposure of the parasites to high
drug concentrations selects for parasites that have activated the marked ES. This
method has been used widely by us and other labs, yet the procedure could result in a
lower switching frequency since activation of only one out of ~20 operational ES is
selected for (82-84).
Despite these difficulties, deletion of genes implicated in DNA repair / recombination
have been tested for their effect on antigenic switching. Mre11 or KU70/80-deficient
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parasites did not exhibit a decreased rate of antigenic switching (85,86). An exception
was the deletion of Rad51, a protein involved in strand invasion between homologous
sister chromatids (87). Deletion of T. brucei Rad51 decreased the rate of antigenic
switching by roughly 10-fold (88). Although the reduction in switching was mild and
results varied between experiments, it is the only report where deletion of a gene
affected antigenic variation. The mild phenotype could be explained by the fact that
the genome of T. brucei contains 5 other Rad51 homologues, which might partially
compensate for the deletion of one (89). Further studies using double mutants of
Rad51 homologues might clarify their role during gene conversion-based antigenic
switching.
In contrast to the decrease of antigenic switching in Rad51-deficient T. brucei,
deletion of the VSG co-transposed region (CTR) caused a dramatic increase in
antigenic switching (76). This result led to the speculation that the CTR could alter
chromatin structure and destabilize the active ES.

Antigenic variation in wild-type African isolates versus laboratory-adapted strains

The frequency of antigenic variation differs dramatically between African
pleomorphic wild-type isolates and laboratory-adapted strains. African isolates switch
at a rate of 10-2–10-4/ cell division, whereas laboratory-adapted strains undergo
antigenic variation at ~10-6–10-7 / cell division (74,82,90,91). The high switching
frequency of pleomorphic strains was not suitable for investigators to study the
molecular mechanisms underlying antigenic switching. Thus, African isolates were
subjected to rapid syringe passaging, a procedure during which parasites are grown in
laboratory mice in the absence of any immune selection (90). Repeated mouse
passaging over several months led to parasites that had a 10,000-fold reduction in
switching frequency and became optimized to grow in laboratory mice (92). These
experiments were confirmed with several wild-type strains, excluding the possibility
that switch reduction is due to genetic differences among wild-type isolates
(75,90,91). To this day, the molecular changes that occur during rapid syringe
passaging have not been addressed. Identification and characterization of these
14

changes are crucial for improving our understanding of the regulatory machinery that
drives antigenic variation.

Expression of surface antigens at telomeric expression sites – a coincidence?

The expression of variant surface proteins from telomeric ES is not restricted to T.
brucei. Several other parasites, such as P. falciparum (the causative agent of malaria),
B. burgdorferi (lyme disease) and P. carinii (pneumonia) transcribe extracellular or
environmental sensing proteins from telomeric expression cassettes (93-95). Why are
these surface antigens expressed from telomeric ES and do telomeres play a role in
regulating antigenic variation? Subtelomeric regions are known to be a hotspot for
recombination (96). Frequent recombination among members of a gene family creates
diversity and increases the organisms chance to successfully adapt to a new
environment.

Telomeres and telomere structure: t-loop

Telomeres (“telos” from the Greek word “far away” or “at end”) are the physical ends
of linear chromosomes. Tetrahymena chromosome ends were the first to be
sequenced and are capped by tandem arrays of TTGGGG (97). Six years later the
sequence of T. brucei telomeres was elucidated. Like their human counterparts, they
consist of ~5–15 kB of TTAGGG repeats (98,99).
In the last decade, several structural features of telomeres have been identified. By
electron microscopy, it was demonstrated that telomeres from mouse and human cells
form a terminal loop structure called t-loop (100). During t-loop formation the
telomere terminus loops back and invades the duplex telomere repeat array (Figure
3A). t-loops are conserved in T. brucei, in micronuclear DNA of Oxytricha fallax and
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Figure 3
Telomere structure: G-overhang and t-loop
A) Telomeres terminate in a 3´ G-rich single-stranded overhang.
By invasion of the duplex upstream region, telomeres can assemble
into a t-loop structure.
B) Electron microscopy of T. brucei t-loops. The size of T. brucei
t-loops can vary from 0.6 kB (right panel) to more than 6 kB (left panel).
Picture credit: Munoz-Jordan et al., 2001

the common garden pea P. sativum (101-103). In mammalian cells, the size of the tloop correlates with the length of a particular telomere (100). In contrast to human
HeLa cells (median size 14 kB) and Oxytricha (5–19 kB), T. brucei t-loops are small.
Their size ranges from 0.3 to 8.0 kB, whereas 65% of t-loops are <1.5 kB (Figure 3B)
(101). The relevance of these size differences is unclear; however, it suggests that
there is a machinery that controls the size of t-loops (101). In mammalian cells, parts
of this machinery have been identified. TRF1, a telomere binding protein has the
propensity to parallel align two telomere fragments in vitro (104). This step might be
necessary to facilitate strand invasion during t-loop formation. TRF2, a telomere
protection factor, can reconstitute t-loops in vitro (105).
Telomeres must ensure genome integrity by protecting chromosome ends from
nucleolytic degradation and illegitimate activation of DNA damage checkpoint
pathways (106-108). By tucking away the very end of the telomere, t-loops offer a
formidable solution to protect chromosome ends from the DNA damage response
machinery, and prevent illegitimate ligation of individual chromosomes.
Invasion of the upstream duplex telomere during t-loop formation requires another
structural feature of telomeres, the G-strand overhang. In 1993, it was discovered that
S. cerevisiae telomeres acquire long, single stranded G-strand 3´ overhang (Goverhangs) late in S-phase (109). G-overhangs are a conserved feature of linear
chromosomes and they play an important role in telomere replication (110,111).

The End Replication Problem: telomere shortening and G-overhang length

In the early 1970’s, Watson and Olovnikov proposed that during semi-conservative
replication, removal of the RNA primer, required to initiate lagging strand synthesis,
results in a terminal gap that cannot be filled by conventional DNA polymerases. As a
consequence of this “End Replication Problem” telomeres should become shorter
with each replicative cycle (Figure 4) (112,113). Harley and co-workers confirmed
this prediction by showing that telomeres of somatic cells (cultured fibroblasts)
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Figure 4
The End Replication Problem
A) During semi-conservative DNA replication, a replication fork approaches the
chromosome end. Lagging strand synthesis (shown in blue) requires an RNA
primer to initiate synthesis of an Okazaki fragment.
B) Leading strand synthesis (shown in red) can result in a blunt ended chromosome
end. Removal of the RNA primer leaves the lagging strand with a terminal gap that
cannot be filled by conventional polymerases.
C) 5´ end processing leads to creation of a terminal G-overhang on both newly
replicated strands. As a result telomeres shorten during each replicative cycle.
The figure illustrates how the rate of shortening correlates with the length of the
G-strand overhang.

shortened during continuous in vitro culture (114). Furthermore it was demonstrated
that elderly have shorter telomeres than young people (115). If telomere shortening
could merely be attributed to removal of the lagging strand RNA primer, telomeres
should shorten at a rate of ~6 bp/population doubling (PD). However, telomere
shortening in human cells was more than 100 bp/PD. What could account for this
difference? As mentioned before, telomeres end in a 3´ protrusion called the Goverhang. By parallel in-gel hybridization of two native DNA gels, using radiolabeled
(CCCTAA)4 and (TTAGGG)4 probes, and by counting the number of single-strand
binding proteins attached to telomere fragments under EM, it was shown that human
telomeres end in long (150–200 nt) G-overhangs (110,111,116,117). Furthermore, the
rate of telomere shortening correlated with the length of the telomere terminal Goverhang (116,118). The length of G-overhangs and their presence on both leading
and lagging strand telomeres suggests, that they are not simply formed by RNA
primer removal, and their creation involves nucleolytic degradation of the C-strand
(111,119).
In S. cerevisiae, G-overhangs are short during most of the cell cycle (12–14 nt) (120).
Exclusively during S-phase, G-overhangs become long and can be detected by in-gel
hybridization (109). Like in human cells, the rate of telomere shortening in telomere
maintenance-deficient yeast correlates precisely with the length of the G-strand
overhang (121,122).
In conclusion, G-overhangs are a conserved feature of eukaryotic linear
chromosomes. The length of the overhang correlates with the telomere shortening
rate, and several lines of evidence suggest that G-overhang formation involves
nucleolytic degradation of the C-strand. Yet, the components involved in nucleolytic
degradation remain elusive.

Telomerase

Conventional polymerases are incapable of replicating linear chromosomes without
gradual telomere erosion. Particularly in unicellular organisms and in germ or cancer
cells, which have the ability to multiply indefinitely, the gradual shortening of
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telomeres during each replicative cycle needs to be compensated for. In Drosophila,
the gradual shortening of chromosome ends is compensated for by frequent
transposition of HeT-A and TART telomere-associated retrotransposons onto
chromosome termini (123). Another solution to solve this problem was identified in
extracts of the ciliate Tetrahymena thermophila and named telomere terminal
transferase or telomerase (124). This purified enzymatic activity had the ability to add
nucleotides onto the 3´ end of oligonucleotides in vitro (124). Further experiments
showed that RNase treatment abolished its activity, suggesting that telomerase is a
ribonucleoprotein (125).

Telomerase RNA

Identification and sequencing of the telomerase RNA component revealed the
presence of a short templating region, complementary to the telomeric G-overhang
terminus (126). In subsequent years, the telomerase RNA component from many
organisms was cloned and provided insight into telomerase function (122,127). The
length of the telomerase RNA ranges from 150 nt in ciliates to 382–559 nt in
vertebrates to >1300 nt in yeast and its primary sequence is highly divergent
(122,128,129) #376]. The templating region generally corresponds to 1.5 telomeric
repeats. Exceptions are human, mouse and K. lactis, whose templating regions are 11,
8 and 30 nt, respectively. (130,131). Despite the differences in length and primary
sequence, a core secondary structure is well conserved within vertebrates and yeast
(129,132-134). The secondary structures of various telomerase RNAs was predicted
by using mFOLD, a program that calculates the lowest free-energy estimates for helix
stability. These predictions were experimentally tested by RNase H cleavage assays
(135). The conserved core encompasses the templating domain, used for overhang
pairing and nucleotide synthesis, a double stranded boundary element 5´ of the
template region, which is thought to interact with, and initiate translocation of TERT,
and a pseudoknot structure, essential for telomerase activity and interaction (133).
Mutational analysis of yeast telomerase RNA revealed structure motifs critical for the
interaction with another member of the telomerase complex, Est1p and the KU70/80
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heterodimer (136,137). Importantly, mutations in the human telomerase RNA gene
have been linked to dyskeratosis congenita, a disease that causes premature hair loss,
osteoporosis, bone marrow failure and abnormal skin pigmentation (138). Tissues that
require constant self-renewal are more susceptible to telomerase dysfunction (139).

Telomerase Reverse Transcriptase TERT

After the identification of the first telomerase RNA, various groups joined the race to
identify the protein component of telomerase. In an impressive set of experiments,
Joachim Lingner succeeded in purifying a small amount of telomerase from Euplotes
aediculatus, a ciliate that contains both a micro- and a macronucleus (140). The
macronucleus contains ~4 x107 DNA molecules, each representing a single gene
flanked by telomeres (141,142). Thus, Euplotes requires large quantities of an
enzyme that can synthesize telomeric repeats (~3 x105 molecules of telomerase). A
biotinylated oligonucleotide complementary to the telomerase RNA component was
immobilized on an avidin column and used as bait to pull down telomerase. The
ribonucleoprotein was eluted by addition of a displacement oligonucleotide (140). A
partial protein sequence of the purified fraction was elucidated using
nanoelectrospray tandem mass spectrometry. It revealed that the 123 kDa telomerase
protein component contained sequence hallmarks of reverse transcriptases (143).
Point mutations in the catalytic reverse transcriptase domain led to telomere
shortening in yeast, and proved involvement of the reverse transcriptase in telomere
length maintenance. The telomerase reverse transcriptase open reading frame
complemented yeast est2 mutants (est = ever shorter telomeres). EST1-4 were
identified in a screen for mutants that had shortened telomeres (121). Telomerase
from fission yeast and human was identified shortly after (144,145).
Telomerase reverse transcriptase has several well-conserved domains: a telomerase
specific T-motif and the reverse transcriptase domains 1, 2, A, B, C, D and E (Figure
5A, underlined). The telomerase N-terminus contains several less conserved domains
(II and III) that are essential for in vivo activity, yet dispensable for reconstituting
activity in vitro (146). Parts of the N-terminus are also necessary for substrate (G21

overhang) binding and interaction with the telomerase RNA (147). Analysis of
affinity purified telomerase from human HeLa cells suggested that the enzyme exists
as a homodimer in vivo (molecular mass of the complex: ~600 kDa; TERT =127 hTR
= 150 kDa) (148,149). Regions within N- and C-terminus of telomerase have been
implicated in dimerization (150,151).
Despite the tremendous attention that telomerase has received in recent years, it
remains unclear how it precisely extends the telomere terminal 3´ overhang. Human
telomerase is a processive enzyme; several repeats can be added during one
replicative cycle. The templating domain of the telomerase RNA is very short (11 nt),
thus, to achieve processivity, the enzyme must dissociate from its DNA substrate and
re-anneal to continue nucleotide synthesis. The states of this reaction cycle for T.
brucei telomerase are illustrated in Figure 5B. In vitro activity studies and cloning of
T. brucei telomere termini suggested that the T. brucei telomerase RNA component
template region consists of 5´-CCCTAACCC-3´. (1) telomerase binds to the telomere
terminal 3´ G-overhang. An RNA–DNA hybrid between the 3 nt RNA templating
region and the telomere 3´ end is formed. (2) Using the RNA as a template, the
reverse transcriptase copies nucleotides onto the 3´ end. Upon reaching the 5´
boundary of the templating region, the enzyme dissociates. It is also possible that the
enzyme dissociates during nucleotide addition. (3). Subsequent translocation places
the terminus again at the active site of nucleotide synthesis. Another round of
telomere repeat synthesis is initiated (4). Very little is known about these reaction
steps, in particular the transition states remain speculative.
In vitro telomerase assays revealed differences between telomerase from various
organisms. Human and ciliate telomerase are very processive and can add numerous
repeats to an oligonucleotide substrate (152,153). In contrast, yeast telomerase is
relatively non-processive, stalls after the addition of every nucleotide and completes
only one round of RNA template replication (131). Interestingly, upon addition of one
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Figure 5
Telomerase Reverse Transcriptase (TERT)
A) Human TERT contains several motifs implicated in processivity, dimerization
and activity. Most conserved among different organism are the T-motif and the catalytic
reverse transcriptase motifs 1,2, A, B, C, D and E (underlined).
B) Schematic representation of the telomerase catalytic cycle at a telomere end. Represented
is the predicted telomerase RNA sequence of T. brucei.
Dissociation from the DNA substrate and reannealing ensure processivity. (1) Telomerase
RNA primes up with the 3' end of the telomeric G-overhang. (2) The reverse transcriptase
copies nucleotides onto the telomere. (3) Upon reaching the 5' end of the template,
telomerase dissociates and (4) realigns the 3' telomere end into the catalytic center.

repeat, yeast telomerase remains tightly associated with its substrate, indicating that
the lack of processivity is not due to a high rate of substrate dissociation (131).
Although many questions about the precise molecular mechanism of telomerase
action remain unanswered, the cellular consequences of telomerase deficiency have
been intensively studied. In the last decade, a link between telomerase, telomere
shortening and cellular senescence has been established. In contrast to somatic human
cells, whose telomeres shorten during each replicative cycle, telomerase maintains
telomere length in the human germline and a majority of tumors (152,154,155).
Normal human cells transfected with telomerase maintained telomere length,
bypassed cellular senescence, and were rendered immortal (156). These and the
works of others established that telomerase activation is an essential step during
tumorigenesis (157,158). Telomerase inhibition, by expression of a dominant
negative allele, or through chemical compounds, led to telomere shortening and
proliferation arrest (159,160). As a consequence, telomerase inhibition has become an
attractive target for anti-neoplastic therapeutics (161).
In conclusion, telomerase action is essential for telomere length regulation and longterm survival of cells. Numerous factors ensure telomere homeostasis by regulating
recruitment of telomerase to the telomere.

A protein-counting model that mediates telomere homeostasis in yeast

In telomerase positive cells, such as human HeLa or unicellular organisms, telomere
length is maintained within a distinct size range. Telomere shortening is compensated
for by repeat addition through telomerase. Short telomeres are preferentially
elongated, while the length of long ones is maintained. Such telomere homeostasis
can only be achieved if information about telomere length is properly relayed to the
telomere terminus and consequently facilitates or inhibits telomerase action.
The machinery facilitating this was elucidated in yeast by seeding a short 80 bp
telomere into strains containing various amounts of telomeric repeats in the
subtelomeric region (40 bp from the “real telomere”) (162). The seeded telomere was
extended by telomerase but the extent of elongation decreased with increasing
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amounts of subtelomeric telomere repeats, always adding up to a total of ~300 bp (80
bp subtelomeric + 220 telomeric; 270 bp subtelomeric + very few repeats telomeric).
Proper transmission of this information depended on the telomere-repeat binding
factor Rap1. Thus, telomere length is controlled by a “protein-counting model” that
regulates telomerase at the telomere terminus. Consequently, the rate of telomere
elongation is inversely proportional to the initial telomere length (162,163).
However, it remained unclear whether telomerase was regulated by manipulation of
its catalytic activity (or processivity) or by regulation of its access to the termini of
telomeres. A recent report showed that the amount of telomeric repeats added onto a
telomere during a single round of replication varied from ~20 to 100 bp, irrespective
of telomere length. But short telomeres were more frequently visited by telomerase
and therefore elongated. Thus, telomerase’ access to the telomere termini was denied
at long telomeres whereas short telomeres granted it. A model was suggested where a
structural change could render the telomere terminus at long telomeres inaccessible to
telomerase. In contrast, short telomeres could not assemble into such a conformation
and remain accessible to telomerase (164).
These and other studies established that telomere associated factors can regulate
telomere elongation by telomerase (165). Similarly to the situation in yeast, a short
telomere seeded onto a human chromosome end by transfection is rapidly elongated
by telomerase until it reaches the size range of the other telomeres in the cell (166).
This result suggested that similar telomere binding proteins could regulate telomere
elongation in human cells.

Telomere length regulation in human cells

The first human telomere binding protein TRF1 was identified in 1995 (167). In the
last 10 years, the components of the human telomere complex have been identified
and their function intensively studied. Figure 6 lists the core factors of this complex
and illustrates their interaction with one another. TRF1 and TRF2 bind to duplex
telomeric DNA as homodimers, using a c-terminal myb DNA-binding domain (168).
TIN2 interacts with both, TRF1 and TRF2, as well as Tankyrase and TPP1 (Figure
25

6B) (169,170). TPP1 connects POT1 with the TRF1 complex but POT1 can also
interact with single-stranded telomeric DNA (Figure 6C) (171). TRF2 recruits hRAP1
to telomeres; and exclusively during S-phase, it also interacts with the MRE11
complex (172). The involvement of these factors in telomere length regulation and
end protection is discussed below.
Overexpression of TRF1 in a telomerase positive cell line led to a gradual decrease in
telomere length without altering telomerase expression levels (173). This experiment
proved that TRF1 is a negative regulator of telomere length. Expression of a
dominant negative allele, which displaced endogenous TRF1 from the telomeres,
resulted in telomere elongation. Chromatin immunoprecipitation of telomeric DNA in
cell lines with long and short telomeres indicated that longer telomeres bind more
TRF1 (171). Similar to yeast, the cell employs a “protein counting model”: more
TRF1 on long telomeres prevents telomerase extension. Another layer of regulation is
added by the fact that TRF1 binding to telomeres is controlled by at least two other
factors: Tankyrase and TIN2. Tankyrase is a poly(ADP-ribose) polymerase (PARP)
that uses NAD+ as a substrate to catalyze the formation of ADP-ribose polymers onto
proteins (174). Overexpression of Tankyrase dissociates TRF1 from the telomeres
and leads to telomere elongation. TRF1 dissociation depends on the PARP activity of
tankyrase and leads to rapid degradation of TRF1 (175,176). Conclusively, Tankyrase
can regulate telomere length by modulating the amount of telomere bound TRF1. A
second modulator is TIN2 (177). TIN2 forms a ternary complex with Tankyrase and
TRF1 (178). Downregulating TIN2 in wild-type or PARP-deficient Tankyrase
backgrounds demonstrated that TIN2 modulates Tankyrase-dependent ribosylation of
TRF1. In conclusion, this complex consists of three negative regulators, TIN2 inhibits
Tankyrase activity, Tankyrase inhibits TRF1’s capability to bind to telomeres, and
TRF1 negatively regulates telomere length. Yet, the question remains, how do
double-stranded DNA binding proteins like Rap1 or TRF1 affect telomerase action at
single-stranded telomere termini?
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Figure 6
Telomere associated factors in human
A) Telomere binding factors: TRF1 and TRF2 homodimers bind directly to
telomeric DNA through conserved myb-domains. Both recruit various other
proteins to form the telomere complex shown in panel B.
B) TRF1 and TRF2 are connected by TIN2. TIN2 interacts with Tankyrase
and TPP1. TPP1 connects POT1 to TIN2. hRAP1 interacts with TRF2.
The MRE11 complex interacts with TRF2 exclusively during S-phase.
C) Telomere associated factors could facilitate t-loop formation.
POT1 can associate with telomeres through its interaction with TPP or
by directly binding to single stranded telomeric DNA.

Factors that bind the telomere G-strand overhang

A key to these questions was provided by the identification of proteins that
specifically bind the telomere terminal G-strand overhang in Oxytricha nova: singlestranded telomere binding proteins alpha and beta (179). The alpha subunit binds
ssDNA through four oligonucleotide / oligosaccharide-binding (OB) folds. Through
structural similarity, human and fission yeast homologues of the alpha subunit were
identified and called POT1 (Protection of Telomeres 1) (180). In humans, POT1
localizes to telomeres through its interaction with components of the TRF1/TRF2
complex. POT1 binds to single-stranded telomeric oligonucleotides in vitro and this
preloading inhibits elongation by telomerase (Figure 6C) (171,181). It was suggested
that long telomeres with more TRF1 could enhance binding of POT1 to the overhang
and restrict telomerase from elongating the 3´ terminus (171,181). Consistent with
this notion, a POT1 mutant, deficient in binding single-stranded DNA led to a
dramatic increase in telomere length (171).
Similarly to human POT1, the single-stranded DNA binding protein Cdc13 plays an
important role in telomerase action at S. cerevisiae telomeres. A temperature sensitive
allele of cdc13 activated the RAD9 checkpoint and induced G2 cell cycle arrest (182).
rad9 / cdc13 double mutants accumulated single-stranded DNA in telomeric and
telomere proximal regions, indicating that Cdc13 might function in telomere
protection or replication (182). Numerous experiments confirmed this hypothesis
(183). Cdc13 recruits two major complexes to the telomere end: through its
interaction with Stn1 and Ten1, Cdc13 protects telomeres and recruits DNA Polα,
which is responsible for lagging strand synthesis, to the terminus (184). Secondly,
through its interaction with another single strand binding protein Est1, Cdc13 recruits
the telomerase complex to the telomere end (185,186). Microarray studies showed
that EST1 transcription occurs in late G1 phase and subsequent experimental
evidence demonstrated that this restricted expression pattern is highly relevant for
telomerase recruitment (187,188). By Chromatin Immunoprecipitation (ChIP) it was
shown that Cdc13 association with telomeres peaks during late S-phase, which is
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consistent with the increased overhang length observed in late S-phase (109).
However, the catalytic subunit of telomerase Est2 was already present at telomeres
during the G1 phase of the cell cycle. This result came as a big surprise since in vivo
telomerase activity has been observed exclusively in S-phase (189). An elegant model
was proposed in which telomerase is recruited to telomeres through the interaction of
its RNA component TLC with the KU70/80 heterodimer (137,190). During late Sphase, EST1 becomes expressed and serves as a linker between Cdc13 and
telomerase, thus mediating telomerase access to the telomere termini (191).

Telomere protection

H.J. Mueller in 1938 and Barbara McClintock in 1941 proposed that genomic
integrity can only be achieved if chromosome ends are protected from activities that
normally repair double-stranded breaks. Telomere-binding factors play an important
role in maintaining genomic integrity. TRF2 binds double-stranded telomeric DNA in
similar fashion as TRF1, through a conserved myb-DNA binding domain (106).
TRF2’s function in telomere protection was elucidated by overexpression of a
dominant negative allele that displaced endogenous TRF2 from the telomere. As a
consequence, telomeres lost their 3´ terminal G-overhang, creating a double-stranded
break and a substrate for non-homologous end joining (NHEJ). Consistent with this
observation, roughly 15% of chromosomes fused with each other. These fusions
depended on the DNA Ligase IV, the main ligase involved in NHEJ (106,192).
Depending on the cell type, TRF2 mediated telomere deprotection initiated p53dependent apoptosis or cellular senescence (193).
Factors that bind the single-stranded portion of telomeres are also involved in
telomere protection. For instance, deletion of S. pombe Pot1 led to dramatic loss of
telomeric sequences and frequent chromosome circularization (180). A mutant allele
of S. cerevisae Cdc13 led to dramatic accumulation of single-stranded DNA in
telomeric and telomere-proximal regions. This suggested that telomeres were not
properly protected and nucleolytic degradation of one strand took place (182).
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In conclusion, telomeres are bound by a number of proteins that regulate telomere
length and protect them from being recognized as double-stranded breaks.

Life without telomerase – alternative lengthening of telomeres

In telomerase-deficient or human somatic cells, telomeres shorten through each
replicative cycle (114,121,122). This molecular clock limits the proliferation capacity
of cells, after which they enter a non-reversible growth arrest called senescence.
Telomerase-deficient cells occasionally escape senescence or apoptosis. Yeast and
human survivor cells acquire the ability to maintain chromosome ends through an
alternative lengthening mechanism (ALT) (194,195). In the absence of telomerase,
Saccharomyces cerevisiae can survive by amplifying subtelomeric repeats (Type I),
or by recombination among telomeres (Type II). Both of these processes depend on
the function of Rad52. In rad52 / exoI-deficient yeast, Type III survivors appear,
which maintain their chromosome ends through palindrome-based amplification of
subtelomeric regions (195,196). In addition to telomere-telomere recombinationbased lengthening, Schizosaccharomyces pombe can overcome the loss of telomeric
DNA by chromosome circularization (197).
Five to twenty percent of human cancers lack telomerase activity and use ALT to
dramatically increase their telomere length (198). Telomere-telomere recombination
appears to be the major mechanism underlying ALT. Nevertheless, fluorescent in-situ
hybridization (FISH) of metaphase spreads of human ALT cells revealed that
telomeric repeats are undetectable at many chromosome ends (198,199). It remains
unclear whether signal-free ends represent short telomeres, how much telomeric DNA
they carry, and whether these ends might be temporarily stabilized until they are able
to undergo recombination. The majority of these human ALT cell lines contain
extrachromosomal circular telomeric DNA, which could serve as a template to
dramatically elongate short telomeres (200,201).
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Telomeres and telomerase in kinetoplastid protozoa

In the early 1980’s, telomeres of T. brucei received considerable attention from the
scientific community. As an example, the sequence of T. brucei telomeric repeats
TTAGGG was determined several years prior to their elucidation in human cells
(98,99).
In contrast to any known organism, telomeres of in vitro cultured or mouse passaged
T. brucei grow at a constant rate of 6-8 bp/PD (202-204). It remains unknown how
telomere homeostasis is achieved in wild-type African parasites. Telomere length
changes can easily be detected by digesting genomic DNA with frequently cutting
restriction enzymes such as AluI, MboI, RsaI or HinfI. These enzymes do not cut in
telomeric repeats, which leaves them intact for length analysis (Figure 7A, left panel).
Terminal restriction fragments, separated on agarose gels and blotted against a nylon
membrane, can then be visualized by hybridization with a radiolabeled telomere
repeat probe (Figure 7A, right panel).
Due to the abundance of unique VSG genes at individual subtelomeric loci, T. brucei
offers an opportunity to study telomere length dynamics at single chromosome end
resolution. Chromosome-internal copies of these VSGs serve as an internal control
(Figure 7B). By hybridization of terminal restriction fragments with VSG 121 and
VSG bR2 probes, for example, we confirmed the previously reported constitutive
growth of T. brucei telomeres. The terminal restriction fragments grow at a rate of
~6–8 bp/PD, whereas the chromosome-internal copies do not change in size over time
(Figure 7B, arrowhead). It was also shown that the active ES telomere is subject to
frequent truncations, but it is unclear whether these truncations are comparable with
the Telomere Rapid Deletions (TRD) observed in yeast and human cells (201,205).
Attempts to establish a link between telomere length at silent and active ES, or the
order of VSG expression remained inconclusive (206,207).
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Telomere length and telomere end sequence

Numerous studies have measured telomere length in several kinetoplastid protozoa.
Telomeres of laboratory-adapted T. brucei range in size from 3–20 kB with an
average size of ~15 kB (101). The telomere terminal sequence (TTAGGG-3´) has
been elucidated by adapter-based cloning (208). This result was also confirmed by
biochemical studies of T. brucei telomerase and suggests that the telomerase RNA
component ends in AAUCCC-5´ (209).
By comparison, L. amazonensis have short telomeres that range in size from 200 bp
–1000 bp, and speculative evidence suggests that they have short (~12 nt) Goverhangs that terminate in GTTAGG-3´ (210,211). L. major and L. donovani
telomeres range in size from 3–20 kB and end in TTAGGGT-3´, indicating that, in
contrast to T. brucei and T. cruzi, the Leishmania telomerase RNA templating region
ends in a different nucleotide (212-214). T. cruzi telomere length varies among
different strain isolates and can be classified into two groups: group I has short
450–1500 bp telomeres, and group II has long 1–10 kB telomeres (215). Like T.
brucei, T. cruzi telomeres terminate in TTAGGG-3´ (216). Telomere length variation
has also been observed in different isolates of S. cerevisiae and wild-type inbred and
laboratory mouse strains (217,218).

Telomere binding activities in T. brucei

Several groups identified factors that, based on their biochemical properties, had the
ability to interact with double-stranded or single-stranded telomeric or telomere-like
sequences in T. brucei. The first to be identified were ST-1 and ST-2; ST-1 is a 39
kDa protein whereas ST-2 appears to be a complex made of five polypeptides,
ranging between 35-55 kDa. ST-1 and ST-2 preferentially bind to telomeric single
stranded (CCCTAA)3 and (TTAGGG)3 oligonucleotides, respectively, yet both
exhibit 5-10-fold higher affinity for single-stranded 29-bp motifs (219-221). This 29bp degenerate T2AG3-repeat element is associated with MC but it remains unclear
whether it is present on all megabase chromosomes as well (17,204,219).
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Another 40 kDa activity that binds to 7 tandem CCCTAA repeats, as well as PolI
promoter motifs was identified independently in another set of experiments (222).
This activity had very similar biochemical properties like ST-1 and all attempts to
further purify this activity and determine its coding sequence failed. Similarly, C1–3
and LaGT1–3, activities, which interact with the telomeric G-rich overhang of T.
brucei and Leishmania amazonensis, respectively, have been identified, partially
purified and analyzed by mass spectrometry (223,224). The molecular masses of T.
brucei C1–3, did not match with any known proteins in the database. In L.
amazonensis LaGT1, a 18-20 kDa protein is the most abundant and specific activity;
LaGT2, a 35 kDa protein has higher affinity to RNA and similarity to Rbp38p, an
unknown protein found in mitochondria and the nucleus of L. tarentolae and T.
brucei; LaGT3, is a 52 kDa homologue of RPA-1 and probably the most interesting
candidate (224). Nevertheless, verification, co-localization, overexpression or
deletion studies have not been performed on any of these proteins, rendering their
involvement in telomere affairs rather speculative.

tbKu70/80

The KU heterodimer, consisting of 70 and 80 kDa subunits, is conserved from higher
eukaryotes to bacteria and archaea, and is best known for its role in repairing doublestranded breaks using Rad52 dependent NHEJ (225). KU has been found in cytosolic
and nuclear fractions of peripheral B-cells. Upon stimulation, KU shuttles to the
nucleus where it is involved in creating a large repertoire of antibodies through
V(D)J-recombination of immunoglobulin genes (226). In S. cerevisiae, KUdeficiency leads to short stabilized telomeres, the persistence of S-phase restricted
long G-overhangs throughout the cell cycle, and inhibition of subtelomeric
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Growth of T. brucei telomeres
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A) Genomic DNA is digested with frequently cutting restriction enzymes AluI,
MboI, and RsaI. Digests are separated by agarose gel electrophoresis, Southernblotted and probed with a radiolabeled telomeric (TTAGGG)n probe (right panel).
Distinguishable bands represent growing telomeric fragments over a time course
of 194 PD (from Janzen et al., 2004).
B) Upper panel: Telomere growth at single chromosome end resolution using EcoRI
that liberate a terminal restriction fragment that can be visualized by using subtelomeric
VSG genes as hybridization probes. Chromosome-internal copies serve as loading control.
Lower panel: Terminal restriction fragments containing VSG 121 or bR2 grow over a
time course of 295 PD (arrowheads). Chromosome-internal copies do not change in size
over time.

transcriptional silencing (TPE) (225,227). In conjunction with Mlp1 &2, KU tethers
telomeres to the nuclear periphery (228,229).
In T. brucei, all but one VSG ES are transcriptionally repressed, and TPE may be
involved in exerting this effect. Consequently, the identification of KU was of great
interest to the trypanosome research community (51,85). tbKU-deficient T. brucei are
viable, not impaired in double-stranded break repair nor is the repression of
transcription at silent ES affected. Through co-immuno-precipitation of GFP and TYepitope tagged KU, and co-localization by immuno-fluorescence microscopy, our
group showed that tbKU forms a heterodimer. KU deficiency leads to progressive
telomere shortening at a rate of 3–6 bp /PD (51). We showed by in-gel hybridization
that, in contrast to S. cerevisiae, deletion of tbKU does not result in the acquisition of
long G-overhangs throughout the cell cycle (51). Interestingly, Conway et al. noted
that, upon dramatic shortening, critically short telomeres appeared to stabilize in
length (85). At the time, we proposed a model where tbKU might be essential for
telomerase recruitment or action at long telomeres, but might be dispensable at short
telomeres (51).

TbTRF

The most characterized telomere binding protein in kinetoplasts to date is tbTRF, the
T. brucei homologue of mammalian TRF2 (230). tbTRF was shown to localize to
telomeres by immuno-fluorescence microscopy (IFM) and Chromatin
Immunoprecipitation (ChIP). Purified tbTRF binds double stranded TTAGGG
repeats, as judged by electrophoretic mobility shift assays (EMSA), and
homodimerizes as shown by yeast two-hybrid analysis. RNAi of tbTRF leads to cell
cycle arrest and a reduction of G-overhang signal in T. brucei. Previously, it was
shown in human that expression of a dominant-negative allele of TRF2 results in cell
cycle arrest, reduction of telomere terminal G-overhang, and chromosome fusions.
Although no chromosome fusions were observed in TRF-deficient T. brucei, the
results strongly suggest that tbTRF is a homologue of mammalian TRF2 (106,230).
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Telomerase activity in kinetoplastid protozoa

Telomerase activity was detected in T. brucei, L. major, L. tarentolae and T. cruzi
(209). The biochemical properties of partially purified T. brucei telomerase (tbTERT)
were analyzed by its ability to extend different end-labeled oligonucleotides. In vivo
experiments already suggested that tbTERT can elongate a variety of different
telomeric substrates (231). Consistent with these results, tbTERT extended input
primers with various telomere permutations in vitro by forming a ladder with a
periodicity of 6 nt. After addition of 6 nt, the enzyme dissociated itself from the
elongated product and repositioned at the 3´ end of the telomere terminus. For reasons
that are not clear, telomerase stalling or translocation gives rise to a band of increased
intensity on the acrylamide gel. Thus by testing telomerase elongation on
oligonucleotides that ended in different sequences, the precise nucleotides added
before translocation mapped the template boundaries of the T. brucei telomerase
RNA template. These results suggested that tbTERT template RNA consists of 3´CCCAATCCC-5´. In comparison to ciliates, processivity of tbTERT was relatively
low (209). Telomerase in T. cruzi (tcTERT) has been characterized to a similar
extent. Telomerase activity was recovered from parasites of four different life-cycle
stages, yet telomerase processivity was very low (addition of 2–3 nt). tbTERT
elongated any telomere oligonucleotide substrate, whereas tcTERT clearly prefers
oligos that terminate in A or T. These results suggested that T. cruzi telomerase RNA
contains a 3´-CCCAATCCC-5´ template region and, that at least in vitro, different 3´
ends have dramatically different elongation efficiencies. The implications of this
result remain speculative, but the authors concluded that tcTERT might rely on itself
(rather than other proteins) to establish sequence specificity with its substrate. Lastly,
like many other telomerases, T. cruzi telomerase exists in a ~670 kDa complex. Since
T. cruzi telomerase itself is ~133 kDa, it is presumed that this molecular weight is
achieved through multimerization or interaction with other associated factors (232).
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Chapter II: T. brucei telomerase, telomere shortening and G-overhang structure
Introduction

In this chapter, we describe the identification, characterization and deletion of
telomerase in Trypanosoma brucei. We show, by comparative sequence analysis, that
tbTERT contains the hallmark reverse transcriptase motifs and the telomerase
characteristic T-motif. We monitored telomere length after deletion of tbTERT and
show that the rate of telomere shortening correlated precisely with the amount of
DNA predicted to be lost due to the end replication problem: 3–6bp/generation.

Identification and characterization of T.brucei TERT

We searched the emerging T. brucei genome data for sequences that could encode the
characteristic motifs of telomerase reverse transcriptase (143). Our original search
yielded a short DNA fragment containing motifs 1, 2, A and B of the reverse
transcriptase domains. The complete TERT sequence was obtained by sequencing
BAC and plasmid clones that covered the telomerase coding region. From these
additional sequence data, we were able to assemble a 3,579 bp ORF, which encodes a
132 kDa protein that contains all the domains that are known to be required for
catalytic activity (Figure 8A). TERT orthologues can also be identified in the recently
completed genome sequences of Trypanosoma cruzi (49.1% identity to tbTERT) and
Leishmania major (33.6% identity), the causative agents of Chagas’ disease and
cutaneous Leishmaniasis, respectively. In contrast, tbTERT shows weak sequence
identity with human TERT (15.6%), reflecting the early divergence of T. brucei in the
evolutionary tree (Figure 8B) (233). Within the T-motif, these three kinetoplastid
protozoa contain a highly conserved insertion, of unknown function, that is not
present in other organisms (Figure 8B and Figure 9). We used RT-PCR to verify that
this insertion was present in the mRNA and did not represent an intron in the genomic
sequence. Figure 9A shows a schematic representation of the telomerase open frame,
the location of the putative intron and the positions of three primers used in PCR
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Alignment of telomerase reverse transcriptase motifs
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A TERT N-terminal region present in kinetoplastid TERT
A) Schematic representation of the telomerase open frame, the location
of the putative intron and the position of three primers used in PCR reaction
to amplify the “intron – like” region on genomic DNA and cDNA.
B) PCR reactions on cDNA and gDNA.
Forward primer C together with primer sets (labeled A and B) was used to amplify
the region of interest on genomic DNA. In parallel, the same primers were used
on cDNA. (-) PCR reactions on “cDNA” that lacked reverse transcriptase during
cDNA synthesis. If the region of interest is indeed an intron, the cDNA
amplification product should be ~80 bp smaller. This size change should
be resolvable on the 1.8% agarose gel we used.

reactions. Both primer sets (labeled A and B) were used to amplify the putative intron
region on genomic DNA and cDNA. If this region were an intron, hence not present
in the mRNA, a size change of ~80 bp in the PCR product would be expected. To
exclude the possibility that the cDNA is contaminated with remaining DNA, we
performed the PCR reaction on “cDNA” that lacked reverse transcriptase during the
synthesis step, and as expected, no band was amplified (Figure 9B). No size
difference between cDNA and gDNA derived PCR products was detected, indicating
that the region in the T-motif is not an intron and a specific feature of kinetoplastid
protozoan telomerase. We do not know anything about the function of this region.

Telomerase deletion

To determine whether tbTERT was a single-copy gene, we digested the genome of T.
brucei with nine infrequently cutting restriction enzymes and hybridized the southern
blot with a probe that covered the entire TERT ORF (Figure 10A). In each digest only
one band hybridized with the probe, indicating that tbTERT is a single-copy gene.
This result was confirmed by the subsequent sequencing of the T. brucei genome,
which showed that tbTERT is located on chromosome 11.
tbTERT was deleted by replacing both alleles with Hygromycin and Puromycin
resistance genes flanked by Actin Un-Translated Regions (UTR). Regions flanking
tbTERT served as targeting sequences to facilitate proper integration (Figure 10B).
Southern blotting, using the tbTERT ORF as a hybridization probe confirmed that
TERT signal is absent from the three homozygous clones (Figure 10C, upper panel).
Subsequent reprobing of the membrane with Hygromycin and Puromycin ORFs
confirmed integration of the marker genes into the tbTERT locus (Figure 10C, middle
and lower panel). Next, we assessed the growth of TERT-deficient clones. In
comparison to wild-type single marker (SM) and heterozygous mutants (+/-), TERTdeficient clones showed no growth impairment (Figure 10D). This allowed us to
monitor changes in telomere length over long periods.
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Telomerase deficiency results in progressive telomere shortening

During a 2.5 months time course (~267 PD), genomic DNA of TERT-deficient
mutants was isolated on a weekly basis and digested with frequently cutting
restriction endonucleases (MboI and AluI), liberating the uncut repetitive telomere
tracts for length analysis on agarose gels. We first visualized the size distribution of
all telomeres, by hybridizing the gel with a radiolabelled (TTAGGG)4 probe (Figure
11). Telomere length initially ranged from 3–20 kbp, and some telomeres were
resolved as discrete bands. Each band displayed moderate progressive shortening.
The lengths of specific telomere bands, of differing size ranges and from different
gels, were measured. The shortening rate, determined by linear regression analysis on
independent chromosome arms, varied from 3–6 bp/PD. The range of 3–6 bp/PD
reflected the resolution limit of accurate size separation on agarose gels.

Telomere shortening at silent expression sites
The presence of unique VSG genes in several subtelomeric regions allowed us to
measure the shortening rate of individual telomeres. PFGE and Southern
hybridization of three clones using VSG 1.8 or bR2 probes, indicated that these cells
contain four copies of VSG 1.8 and three copies of VSG bR2 (Figure 12A): two
copies of VSG 1.8 and one copy of VSG bR2 are located at chromosome-internal sites
and two are subtelomeric (Figure 12B, right panel). DNA samples from a 220 PD
time course were digested with enzymes that cut either upstream (EcoRI for VSG
bR2) or inside (BglI for VSG 1.8) a VSG open reading frame, releasing a terminal
restriction fragment that was visualized on a Southern blot using a VSG 5´ region as
the hybridization probe (Figure 12B).
Restriction fragments containing chromosome-internal copies of VSG 1.8 do not
change in size, whereas the subtelomeric fragments gradually shorten (arrowheads in
Figure 12B, upper panel). During 220 PD, the terminal restriction fragment shortened
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Deletion of telomerase and growth curve of telomerase-deficient mutants
A) T. brucei telomerase is a single copy gene. Restriction digest with various enzymes
that do not cut within the TERT orf. Southern blotting and subsequent hybridization using
the TERT orf as a probe.
B) Schematic representation of the strategy used to replace TERT with drug resistance
confering marker genes. Both alleles were replaced by the hygromycin phosphotransferase
gene (flanked by actin Untranslated Regions) andthe Puromycin acetyl-transferase gene,
respectively.
C) Southern Blot confirming deletion of both TERT alleles. Upper panel: Membrane was
probed with the TERT ORF. Middle and lower panel: the same blot reprobed with
Hygromycin and Puromycin ORFs.
D) Deletion of tbTERT does not affect growth of Trypanosoma brucei. Growth curve of
three independent tbTERT-deficient clones in comparison to wild-type single marker (SM).
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Overall telomere shortening in telomerase-deficient mutants
Over the course of 267 population doublings (PD), genomic DNA
was isolated at intervals of ~26 PD and digested with MboI and AluI.
Terminal restriction fragments were visualized, using a radiolabelled
(TTAGGG)4 probe. ImageQuant software (Molecular Dynamics) was
used to distinguish individual bands and determine their shortening rate.

by about 1,000 bp, corresponding to an average telomere shortening rate of ~4.5
bp/PD. Telomere shortening was also observed at VSG bR2 ES (Figure 12B, lower
panel). The two subtelomeric copies are subject to progressive shortening (marked by
arrowheads) and the chromosome-internal copies remain at the same length. Again,
telomerase deficiency resulted in a loss of ~950 bp during 220 PD, confirming the
shortening rate of 4–5 bp/PD. The results of several independent experiments are
summarized in Table 1.

TABLE 1:
Shortening rates at different telomeres
in independent experiments
Bulk telomeres

bp/PD
4.4
5.6
5.4

Silent ES telomeres

bp/PD

VSG bR2

3.5

VSG bR2

4.8

VSG bR2

3.1

VSG 121

3.2

VSG 1.8

4.9

VSG 1.8

4.5
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Figure 12
Progressive telomere shortening at silent expression sites
A) By separation of individual chromosomes by PFGE and southern blotting using
VSG 1.8 (upper panel) and bR2 (lower panel) probes, we identified the copy numbers
of these VSG. The signal on top of the lower panel is derived from chromosomes that
remained trapped in the slot.
B) Terminal restriction fragment analysis of silent ES telomeres harboring VSG 1.8
(upper panel) and VSG bR2 (lower panel) in the telomerase-deficient mutant. Time
of culturing is indicated in population doublings (PD). Telomeric fragments containing
VSG 1.8 and VSG bR2 (arrowheads) gradually shorten. Right panel: schematic
representation of VSG 1.8 and bR2 genes and positions of BglI and EcoRI sites used in
the respective DNA digests. Bars indicate the probes used for hybridization.
Bands labeled * are due to cross hybridization of the probe with other VSGs.

To verify that the observed phenotype can be attributed to telomerase deletion, we
complemented TERT-deficient clones with a tetracycline inducible vector, containing
the tbTERT ORF. Re-introduction of tbTERT resulted in telomere elongation and
reversed the telomere shortening phenotype and these results will be discussed in
more detail in chapter IV. Furthermore, the actively transcribed ES telomere is
subject to frequent terminal deletions, and it is therefore not suitable to accurately
determine the rate of progressive shortening in the absence of telomerase (202-204).
The consequences of telomere shortening at the active ES will be discussed in
Chapter V.

T. brucei G-strand overhangs are undetectable by conventional in gel hybridization

In all studied organism, the rate of telomere shortening in the absence of telomerase
correlates with the length of the G-overhang (111,116). In S. cerevisiae, telomerase
deficiency leads to a telomere decline that correlates precisely with the predicted
shortening due to the end replication problem, and with the length of G-overhangs
found outside of S-phase (120-122). The moderate telomere shortening rate observed
at bulk telomeres and at several silent ES telomeres in telomerase deficient T. brucei,
led us to investigate the length of the G-overhangs using a conventional in-gel
hybridization assay. This assay permits the detection of single-stranded regions larger
than ~30 nt on digested genomic DNA fragments (109).
DNA was digested with frequently cutting restriction enzymes and run in parallel on
two agarose gels, which were then dried at room temperature. To detect G-overhangs,
one gel was hybridized with a radiolabelled oligonucleotide probe complementary to
the G-rich strand (Figure 13, (CCCTAA)4 probe). As a negative control, and to test
whether the DNA denatured during isolation and handling, the duplicate gel was
probed with a non-complementary probe (Figure 13, (TTAGGG)4 probe). To verify
equal loading, both gels were denatured and re-probed (Figure 13, lower panels). Due
to the large number of MC, the T. brucei samples contain 10–100-fold more telomeric
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Figure 13
G-overhang Assay in telomerase-deficient T. brucei
T. brucei G-overhangs are undetectable using a conventional in-gel hybridization
overhang assay. Overhang assay in wild-type bloodstream T. brucei, telomerasedeficient T. brucei and human HeLa cells (positive control). Arrows on the top of
the gel indicate the increasing amounts of digested DNA loaded onto the gel (wild-type
and tbTERT-/-, 0.5, 1.0 and 1.5 µg; human HeLa DNA, 5.0 and 7.0 µg).
Upper panels: native gels were hybridized with (TTAGGG)4 or (CCCTAA)4 probes.
The arrowhead indicates the G-overhang detected on human HeLa DNA.
Exposure time: 84 h.
Lower panels: equal loading of samples was confirmed by denaturation and rehybridization of the gels. Exposure time: 5 h.

DNA than does the same quantity of human DNA. Despite this abundance of
chromosome ends, no G-overhang-specific signal was detected by in-gel
hybridization. G-overhangs were readily detected on the positive control, human
HeLa DNA, as indicated by the arrowhead in Figure 13. Whereas TERT-deficiency
did not lead to detectable changes in G-overhang length, a slight decline in telomere
length and signal intensity were visible (Figure 13, right lanes) as a consequence of
telomere shortening during continuous culture. We also tested whether G-overhang
length varies between T. brucei isolated from different life cycle stages. As expected,
no significant change was observed between procyclic and bloodstream trypanosomes
(Figure 14). These experiments were repeated extensively, using hybridization and
washing temperatures that varied from 20°C to 50°C and using different T. brucei
clones, including wild-type isolates, and the results were indistinguishable.

G-overhang structure in tbKU80-deficient trypanosomes

S. cerevisae telomeres acquire a long single stranded G-overhang during S-phase
(109). During the rest of the cell cycle, overhangs are short (12–14 nt) and
undetectable by conventional in-gel hybridization (109,120). In yeast, deletion of the
KU70/80 complex, involved in non-homologous end joining, leads to detectable long
G-overhangs throughout the cell cycle (227). To further test the sensitivity of our
assay and to examine whether the loss of tbKU80 would alter G-overhang structure,
G-overhang assays were performed on KU-deficient T. brucei (Figure 15). DNA was
isolated, digested with MboI and AluI and separated on agarose gels. On dried native
gels hybridized with a radiolabeled (CCCTAA)4 oligonucleotide probe, human Goverhangs were clearly detectable in this sample (Figure 15, upper left panel,
arrowhead). A (TTAGGG)4 probe was used to confirm that the DNA was still in its
native condition (Figure 15, upper right panel). No overhang signal was detectable in
DNA derived from either wild-type or tbKU80-deficient trypanosomes with the
(CCCTAA)4 probe, despite loading at least 10-fold more trypanosome telomeric
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Figure 14
G-overhang: procyclic form compared to bloodstream form T. brucei
Upper panel: native in-gel hybridization using C- and G-strand specific probes.
Arrowhead indicates G-overhangs on human HeLa DNA.
Lower panel: same gels upon denaturation and rehybridization with the same probes
ensure equal loading. Increasing amounts of each DNA sample were loaded: T. brucei
DNA: 0.5, 1.0 and 1.5 µg; human HeLa DNA, 5.0 and 7.0 µg
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Figure 15
G-overhang structure in KU80-deficient T. brucei
DNA was extracted from tbKU80-deficient cells (tbKU80-/-), wild-type cells
(wild-type), and HeLa cells (human) and digested with MboI and AluI restriction
enzymes. Different amounts of DNA (0.5, 1.5 and 5.0 µg for T. brucei and 5 and
7 µg for human) were separated by gel electrophoresis and analyzed with radiolabeled probes (left panels and right panels). Equal loading was verified by
denaturation and re-hybridization (lower panels).

DNA compared to the HeLa cell sample as is evident after denaturation and rehybridized with the same probes (Figure 15, lower panels).
Nevertheless, tbKU plays an important role at the telomeres; its deletion leads to
telomere erosion at precisely the rate of TERT-deficient T. brucei: 3–6 bp/PD. Thus
tbKU is likely to be involved in either telomerase recruitment or activation. However,
in contrast to yeast, tbKU does not play a role in establishing proper telomere
terminal structure (51). As the detection limit of this assay is ~30 nt, we conclude that
trypanosomes have short overhangs and that, unlike yeast, tbKU80 has no apparent
influence on overhang structure in T. brucei.

T. brucei G-overhangs are not degraded during DNA isolation

To test whether G-overhangs might have been degraded by a hypothetical nuclease
activity in the T. brucei lysate during DNA isolation, we mixed HeLa-cell DNA and
T. brucei cells, then re-isolated DNA from the mixtures, reasoning that the HeLa cell
G-overhangs would also be degraded in the mixture (unless the putative nuclease was
tightly tethered to trypanosome telomeres, and only acted in cis). After DNA
isolation, the telomeric tracts were separated on agarose gels and overhang assays
were performed (Figure 16, lanes 7–18). The HeLa G-overhang signal (arrowhead)
was undiminished after re-isolation in the presence of T. brucei cells. Lanes 4–6
confirm that G-overhangs cannot be detected on much larger amounts of T. brucei
telomeric DNA. The gel was then denatured and re-probed to verify the ratios, as
determined by the telomere signal (quantified using a phosphorimager), of T. brucei
in the mixed samples (Figure 16, lower panel, lanes 7–18). Furthermore, the 100-fold
higher relative abundance of telomeric repeats in T. brucei DNA is readily apparent
when equal amounts of T. brucei and HeLa DNA are loaded (Figure 16, lower panel
lanes 1–6).
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Figure 16
HeLa cell G-overhangs are not degraded during DNA isolation in the presence of
T. brucei cell extracts
Upper Panel lanes 1–6: the proportion of telomeric DNA in T. brucei is 100-fold
higher than in HeLa cells. The samples contained 0.5, 2.5 or 5.0 µg of MboI- and
AluI-digested DNA of HeLa cells (HeLa: lanes 1–3) or wild-type T. brucei (BF:
lanes 4–6). Upper Panel lanes 7–18: the HeLa G-overhang signal is not diminished
when telomeres are isolated from mixtures of HeLa DNA and T. brucei cells.
Increasing numbers of T. brucei cells were mixed with 0.5, 2.5 or 5.0 µg HeLa
DNA. The amounts of T. brucei cells are such that they contributed to the mixtures
1.9-, 2.5-, 3- or 3.6- fold as much telomeric DNA as the HeLa cells.
Lower Panel: the same gel after denaturation and re-probing.
Increasing amounts of T. brucei DNA are evidenced by the characteristic banding
pattern of T. brucei telomeric DNA.

Enzymatic modification of T. brucei telomeres

As an additional control, because we could not detect any G-overhang signal on T.
brucei telomeres, we created artificial G-overhangs and detected them by in gel
hybridization (Figure 17). Artificial G-overhangs can be created by treating T. brucei
DNA with bacteriophage T7 (Gene 6) exonuclease, as previously described
(100,234). T7 (Gene 6) exonuclease specifically creates 3´ G-overhangs by
degradation of the 5´ C-rich strand (Figure 17A). After enzymatic modification, T.
brucei DNA was digested to liberate telomeric tracts and a G-overhang-specific
signal could be detected by in-gel hybridization using a (CCCTAA)4 probe (Figure
17, upper left panel). The gel distribution of the created overhang signal was similar
to the distribution of T. brucei telomeres (compare upper and lower panels of Figure
17), indicating that G-overhangs were created at telomere termini. To verify that T7
(Gene 6) exonuclease exclusively degraded the C-rich strand and to test whether the
DNA was still in its native condition, a duplicate gel was probed with a noncomplementary (TTAGGG)4 probe (Figure 17, upper right panel), We also tested
whether Exonuclease I, a 3´ single-strand-specific exonuclease (Figure 17A), would
have any effect on T. brucei DNA. As expected, Exonuclease I had no effect on
hybridization of probes to either the G or C-rich strands (Figure 17). This experiment
shows that artificial G-overhangs could be created on T. brucei telomeres in vitro and
detected by in gel hybridization, although the exact size of these overhangs was not
determined.

G-strand overhangs are detectable on concentrated minichromosomes by PFGE

The genome of T. brucei consists of 11 large MBC, 5–7 IC and ~100 MC, that can be
separated by PFGE (14,15). Under the used conditions, the 11 MBC migrate in the
middle of the gel and are well separated (Figure 18, right panels). IC can be partially
resolved but MC are focused at the bottom of the gel. To investigate whether G-
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Figure 17
Creation of artificial G-overhangs by enzymatic modification of T. brucei DNA
A) T7 Gene 6 exonuclease specifically degrades the 5´ DNA terminus to create 3´
overhang. Exonuclease I attacks 3´ overhangs.
B) Upper panels: native gels, increasing amounts of DNA (0.5 µg and 0.75 µg) were
used. DNA was modified as indicated on top of each lane: T7 (Gene 6) exonuclease
(far left), exonuclease I (far right lanes) or unmodified (-). Duplicate gels were
hybridized with (CCCTAA)4 (left panel) or (TTAGGG)4 (right panel). A G-overhang
specific signal can be detected by hybridization with (CCCTAA)4 probe (left panel).
Lower panels show the same gels after denaturation and re-hybridization with the same
probes.
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Figure 18
T. brucei G-overhangs are detectable by PFGE-overhang assay
Left panels: Native gels were run in parallel, dried and hybridized with (TTAGGG)4
and (CCCTAA)4–probes. Weak G-strand overhangs signal can be detected on abundant
MC (arrowhead). Right panels: Gels upon denaturation and re-hybridization serve as a
loading control. MBC and IC can be partially resolved whereas MC migrate at the
bottom of the gel.

overhangs are detectable on highly concentrated MC, two gels were run in parallel,
dried and hybridized with (TTAGGG)4 and (CCCTAA)4 probes as described before.
Using this technique, a very weak G-overhang signal can be detected on MBC and
IC. A robust G-overhang signal can be detected on MC (Figure 18, left panel,
arrowhead). To verify the amount of DNA loaded in each lane, the gels were
denatured, neutralized and re-hybridized with the same probes.
About 80% of telomeric signal on denatured conventional overhang assays is derived
from MC (Figure 13). Since this signal cannot be detected by conventional overhang
assay, we conclude that it is a consequence of the high concentration of telomere ends
in a small area of the gel. Similarly, short (12–14 nt) yeast G-overhangs were recently
detected by concentrating telomeres at one position in the gel (120).

Discussion

In this chapter, we presented the identification and characterization of T. brucei
TERT and demonstrated that its deletion results in progressive telomere shortening at
a rate of 3–6 bp/PD.
The shortening rate of 3–6 bp/PD is comparable to that observed in telomerasedeficient S. cerevisiae, and reflects the amount of telomeric DNA predicted to be lost
as a consequence of the end replication problem (121,122). In other organisms, the
rate of telomere shortening correlates with the length of the G-strand overhang
(116,118). A previous study suggested that T. brucei telomeres terminate in singlestranded regions that range in size from 75–225 nt (101). Therefore, the moderate rate
of telomere shortening that we observed in the absence of telomerase was
unprecedented and led us to investigate G-overhang length, using a conventional ingel hybridization technique (109). We were unable to detect any G-overhang signal
on wild-type, TERT- or KU-deficient mutants. We then demonstrated that any
putative T. brucei G-overhangs were not being degraded during DNA isolation, and
we were easily able to detect artificially created G-overhangs. Furthermore, we were
also able to detect G-strand specific signal on MC by PFGE-overhang assays. Taking
into consideration the moderate rate of telomere shortening in the absence of
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telomerase, our results strongly suggest that G-overhangs in T. brucei are short (<30
nt) and therefore undetectable by conventional in-gel hybridization, and that T. brucei
might maintain their chromosome ends in a similar fashion to S. cerevisiae. While
about 50% of plant chromosome ends harbor overhangs longer than 20–30 nt, the
remaining telomeres have overhangs smaller than 12 nt or might be blunt ended and
this could also be the case in T. brucei (235). We also cannot exclude the possibility
that T. brucei telomeres might transiently acquire longer G-overhangs during a
particular stage of the cell cycle. However, considering the sensitivity of our assays
and the excessive amounts of telomeric fragments loaded onto the gels, we think this
is unlikely.
Our data suggest that T. brucei G-overhangs are short, yet T. brucei telomeres
assemble into a t-loop structure (101). This supports the notion that t-loops can be
formed with short overhangs in vivo (105). Others have proposed telomerase as a
potential drug target for T. brucei. Considering the low rate of telomere shortening,
our results do not encourage this possibility.
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Chapter III: Consequences of telomere shortening at the silent ES
Introduction
Telomeres of somatic human cells gradually shorten during each replication cycle.
Although the eventual consequences of telomere shortening are manifested by
cellular senescence and apoptosis, telomerase-deficient cells infrequently escape
senescence or apoptosis and become survivors (114,236). Yeast and human survivors
can maintain chromosome ends through Alternative Lengthening of Telomeres (ALT)
(194,195). Telomerase-deficient S. cerevisiae can survive by replenishing
chromosome ends through RAD51-dependent amplification of subtelomeric Y´ repeat
elements or RAD50-dependent recombination among telomeres (237,238). Both
types of survivors depend on the function of Rad52 and presumably involve breakinduced replication (195,239). Cells lacking telomerase, Rad52 and ExoI can survive
by palindrome-based amplification of subtelomeric regions. Furthermore, S. pombe
can overcome the loss of telomeric DNA by circularization of its chromosomes
(196,197). A small percentage of human cancers lack telomerase and utilize ALT to
increase their telomere length (198).
In this chapter we describe the consequences of telomere shortening in the context of
the three different chromosome types in T. brucei: MBC, IC and MC. In particular we
focus on silent VSG ES located on MBC.

Results
Appearance of slow migrating, telomere repeat-containing DNA in long-term
cultured T. brucei
The average telomere of the Lister 427 laboratory strain used in these studies
measures ~15 kb (101). To monitor long-term telomere shortening and its
consequences, several independent TERT-/- clones were continuously cultured without
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any selection regime for ~2.5 years. After ~1 year in culture, telomeres of a TERTdeficient clone shortened significantly, and a dramatic reduction of telomere signal
was evident after ~2.5 years of continuous propagation (Figure 19). A slowly
migrating band also appeared in extensively propagated TERT-deficient strains,
which could represent circular telomeric DNA (Figure 19, asterisk). To investigate
whether the slow migrating band represented telomeric circles, we separated genomic
DNA by 2-D gel electrophoresis (Figure 20) (201). Wild-type single marker, longterm cultured TERT-deficient T. brucei and human ALT cell line Saos-2 (positive
control) were separated in the first dimension, each lane was cut out of the gel,
perpendicularly embedded and separated in the second dimension. To visualize
telomeric repeats, we performed in-gel hybridization using a (TTAGGG)4 probe.
Extrachromosomal circles in DNA from human ALT cells are readily detectable by 2D gel electrophoresis. No circles were detected in DNA from long-term cultured
TERT-deficient T. brucei, despite loading double the amount of DNA (Figure 20A,
compare right and left panels). To test whether telomeric circles could be detected in
T. brucei, we separated equal amounts of wild-type and TERT-deficient DNA on 2-D
gels and failed to detect circular DNA in T. brucei (Figure 20B). Furthermore, we
cannot exclude the possibility that the band observed in Figure 19 is too large to be
separated even on a 2-D gel and remains stuck in the slot. To further characterize the
nature of this band, we performed several experiments (Figure 21). First, we tested
whether the band is susceptible to Bal31 digestion (Figure 21A). Exonuclease Bal31
attacks DNA ends and nicked DNA. We incubated DNA and enzyme for 60 minutes;
at frequent intervals (15, 30 and 60 minutes) we took a sample, phenol-chloroform
extracted the DNA and digested it with MboI and AluI. As shown in Figure 21A, the
slow migrating band is susceptible to Bal31 digestion suggesting that it represents
linear or nicked circles. The extent of Bal31-dependent telomere erosion is
graphically represented in the right panel of Figure 21A. Thus, this experiment does
not reveal much about the nature of the band.
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Figure 19
Telomere loss in long-term-cultured telomerase-deficient T. brucei.
Telomerase-deficient cells exhibit gradual telomere shortening at a rate of 3–6 bp / PD
during 6 week time courses after 1 or 2.5 years in continuous culture. DNA was digested
with MboI / AluI and hybridized using a (TTAGGG)4 probe. Equal loading was ensured
by quantification of digested DNA prior to loading using a fluorometer. Loss of telomeric
DNA is reflected in the decrease in telomeric signal. (*) indicates the appearance of a high
molecular band in long-term cultured telomerase-deficient cells.
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Failure to detect extrachromosomal telomeric circles in T. brucei by
2-dimensional gel electrophoresis
A) MboI / AluI digested DNA of T. brucei TERT-/- mutant and human ALT
cell line Saos-2 (positive control) separated as described by Fangman and
Breyer. To visualize telomeric fragments, gels were dried and in-gel hybridized, using a radiolabeled (CCCTAA)4 probe. 8 µg Saos-2 DNA and 16 µg of
T. brucei TERT-/- DNA was loaded.
B) Comparison between telomerase-deficient cell line (left) and wild-type T. brucei
(right). Equal amounts of DNA were loaded for both samples (~8 µg). Note the
dramatic reduction of telomere signal in the long-term cultured TERT-/- cell line.

Next we tested whether the band could represent previously identified
extrachromosomal circles (240). These circles consist of highly repetitive NRelements (digested by NlaIII) which contain imperfect telomere repeat sequences and
are found in Lister 427 and other isolates yet, curiously, are absent from the genome
sequencing strain TREU 927 (240). Nothing is known about the relevance or function
of these extrachromosomal circles. We tested whether these circles could be
amplified in long-term cultured TERT-deficient T. brucei (Figure 21B). Digestion of
DNA with NlaIII gives rise to a smeared ladder, representing the repetitive NRelement. Southern blotting using an NR-hybridization probe, in comparison with
DNA loading (as judged by Ethidium bromide staining of the gel) revealed no
difference in signal intensity between wild-type or long-term cultured T. brucei
(Figure 21B, upper and lower panel). We addressed by native in-gel hybridization
using strand-specific (CCCTAA)4 and (TTAGGG)4 probes, whether the slow
migrating band could represent single-stranded DNA (Figure 21C). The band could
not be detected on the native gels, indicating that it is not single-stranded (Figure
21C, left two panels). Subsequent denaturing and rehybridization of the gels
confirmed the presence of the band and equal loading between lanes (Figure 21C,
right two panels, arrowhead). Note also the dramatic difference in telomere signal
between parental and long-term cultured TERT-deficient cell lines. To test whether
the band represents individual telomeres that have undergone dramatic elongation, we
separated chromosomes by PFGE (Figure 21D). Although preliminary, we did not
detect a dramatic increase of telomeric signal on any chromosome (Figure 21D, lanes
2.5 years in culture). Note the increase of telomere signal in long-term cultured cells
complemented with telomerase (lane: +TERT). The nature, origin and significance of
the slow migrating band remains completely unknown.
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Characterization of the slow migrating band
A) The band is susceptible to Bal 31 digestion. Right panel:
quantified telomere signal decreases over time of Bal 31 treatment.
B) Long term cultured telomerase-deficient mutants do not accumulate
extrachromosomal NR- circles.
C) Overhang assay: the slow migrating band is double stranded.
Left two panels: no signal is detectable on native gels. Right two panels:
The slow migrating band is visible on denatured gels in long-term cultured
telomerase-deficient clones (TERT-/- clones, arrowhead). 927 is the strain used for
the genome sequencing project.
D) PFGE of long term (1.5 and 2.5 years) telomerase-deficient mutants.
No dramatic amplification of telomeric DNA occurs on individual chromosomes.

Minichromosome loss in long-term cultured telomerase-deficient T. brucei

To measure the decline in telomere signal in different chromosome classes, gels were
dried and probed with a radiolabeled (TTAGGG)4 probe (Figure 22A). To ensure
equal loading, the telomeric signal was normalized to a 50-bp repeat signal, which is
uniquely present in long arrays upstream of ES promoters (Figure 22A, right panel).
Comparable results of telomere decline were obtained when a single copy gene, the
Puromycin ORF located on chromosome 11, was used as a loading control (Figure
22B, upper and lower panel). Quantitative analysis of these blots revealed that the
telomere signal on MBC declined to ~12% of its initial intensity after ~2.5 years in
culture. Surprisingly, the telomere signal on MC reproducibly decreased to ~6%
(Figure 22A, middle panel). We also observed aberrant migration of IC, which will be
discussed later (Figure 22A, right panel, arrowhead).
To investigate what could account for this difference of telomere loss between MBC
and MC, and to study the effects of telomere loss on MC stability, we analyzed the
karyotype of TERT-deficient cell lines in more detail by hybridization to a 177-bp
repeat motif that is unique to MC (Figure 23A, lower panel). The 177-bp repeat signal
decreased to approximately half of its initial intensity, relative to 50-bp and MBCinternal loading controls, over the course of ~2.5 years, as graphically represented in
figure 23B. These results were reproducible for all independently propagated clones.
If MC had fused to each other, the 177-bp signal could have been redistributed over
the gel and thereby reduced in the designated MC region. Although we did not
observe any obvious chromosome fusions, we also quantified MC in unfractionated
DNA by ‘slot blot’ (Figure 23C). Quantitative phosphorimager analysis of four
independent experiments confirmed that the 177-bp MC signal was reduced to ~50%
of its initial intensity (Figure 23D). We attribute the decline of 177-bp signal to loss
of MC. This interpretation is consistent with the 50% reduction in TTAGGG signal
on MC compared to MBC (Figure 22).
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Genomic rearrangements at intermediate chromosomes

We noted new bands in the region where IC migrate. These bands hybridized with a
50-bp probe and no signal was obtained by using the MC-specific 177-bp probe
(Figure 22A, arrowhead). By using PFGE conditions that specifically separate the ~5
IC, and hybridization with 50-bp probe, we confirmed that some IC in long-term
culture TERT-deficient T. brucei migrated slower on the gel (Figure 24A,
arrowheads). It is hard to judge from this gel whether the number of IC was reduced
to 4 or whether two IC co-migrate. The slowest migrating band lies beneath the
compression zone where resolution is limited. These changes could be the result of
chromosome fusions or rearrangements. We confirmed the origin of these
rearrangements to IC by using IC-specific genes VSG 17-21 (Fig. 24B, left panel) and
VSG 17-13 (Figure 24B, right panel), as hybridization probes. However, since we
have very little understanding of IC function or relevance, we did not investigate
these events further.
We also observed one example of a rearrangement among MCB, which is consistent
with the very infrequent rearrangements observed previously, and with the fact that
the diploid chromosomes of T. brucei can differ greatly in size, due to variations in
long chromosome-internal repetitive regions, transposon-like sequences and other
pseudogenes that accumulate in large subtelomeric regions and possibly facilitate
recombination (Figure 22A, right panel, 1 year time point) (241,242).
In conclusion, no significant rearrangements were detected in MBC using 50-bp
repeat and chromosome-internal hybridization probes (Figure 22, 23). Next, we tested
whether dramatic telomere shortening, loss of MC and rearrangements among IC, led
to any growth defect in long-term-cultured telomerase-deficient strains. As judged by
a growth curve over 11 days, telomerase-deficient clones (1–4) reproducibly grew
slightly faster than the wild-type single marker strain (Figure 25A). Telomerasedeficient clones were continuously propagated for ~2.5 years, which could adapt
them better to in vitro culture and explain their slight growth advantage. To address
whether telomerase-deficient strains have impaired viability, we subcloned 50 cells
into 96-well plates and counted positive wells after 4–5 days. Figure 25B represents
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Figure 25
Long-term cultured telomerase-deficient mutants have no growth defect
A) Growth curve of long-term cultured telomerase-deficient T. brucei
(Clone 1-4) in comparison to wild-type single marker.
B) Viability of five long-term cultured telomerase-deficient clones in
comparison to wild-type, assessed by subcloning 50 cells of each strain
into 96-well microtiter plates.
Standard deviation for 3 experiments per clone is shown.

results of 3 independent experiments with 5 telomerase-deficient clones and indicates
that viability was not impaired in long term cultured TERT-/- mutants.

Telomere length stabilization in the absence of telomerase

To study what happens when telomeres become critically short, we monitored
telomere shortening of several MBC at frequent intervals for ~2 years. After two
years of continuous culture, a 21-week time course was performed with three
independently cultured clones (Figure 26A). During this time course DNA was
isolated in weekly intervals. Genomic blotting with numerous unique silent telomeric
VSG probes identified ES, whose telomere had become critically short and allowed us
to study the consequences of dramatic telomere loss at single-chromosome resolution.
We first investigated the fate of the silent VSG 121 telomere. Our strain contains three
copies of VSG 121, only one of which is telomeric. A terminal restriction fragment
containing part of VSG 121, released by digestion with EcoRI, gradually shortened
during the first two weeks of observation (Figure 26A). Between weeks 3–5, the rate
of shortening decreased and the length of this restriction fragment ultimately
stabilized (weeks 6-11). Thus, the length of the VSG 121 chromosome end remained
stable during several additional months of continuous culture. We confirmed this
result by analyzing the VSG 121 chromosome end in a second independent clone,
using a different restriction enzyme to liberate the terminal fragment (Figure 26B). To
exclude the possibility that stabilization is occurring exclusively at the VSG 121
telomere, we also analyzed a second silent ES telomere (VSG bR2) (Figure 26C and
D). There are 4 copies of VSG bR2, two of which are ES-linked (arrowhead and
asterisk). Non-telomeric VSG bR2 restriction fragments did not change in size but the
ES-linked fragments gradually shortened. One ES-linked copy of VSG bR2 had a
short telomere (asterisk) that allowed good resolution of size changes on an agarose
gel. This telomere progressively shortened up to week 12 and then stabilized. At
week 14, a clone was picked out of the population and kept in culture for an
additional 13 weeks (Figure 26D). The VSG bR2 band was initially sharp (week 16).
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Telomere stabilization at short silent VSG 121 and VSG bR2 ES telomeres
Time of culture is indicated in weeks above each lane (1 week corresponds to
~24 population doublings). Bands corresponding to chromosome-internal copies
of VSG 221 and bR2 do not change in size.
A) 3 TERT-deficient clones were kept in continuous culture for ~2 years.
Terminal restriction fragment analysis with several probes was then performed during
a time course of 21 weeks; parts of these time courses are shown in panel B-E.
B) Stabilization of the VSG 121 terminal restriction fragment (*) liberated by
EcoRI occurred at week 5 of the time course.
C) VSG 121 telomere stabilization after 10 weeks of culture analyzed in a
second clone using BglI digestion (chromosome-internal BglI fragments
migrate higher and are not shown).
D) EcoRI liberates the two telomere-linked copies of VSG bR2. One copy is
located in an ES with a long telomere (arrowhead) and the second copy is
located in an ES with a shorter telomere, whose length stabilized after 12 weeks (*).
E) The population from panel C was cloned at week 14 and one clone was
propagated for an additional 13 weeks. The short telomere (*) remained stable
throughout the remaining 13 weeks, whereas the longer terminal restriction
fragment continuously shortened (arrowhead).
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Figure 27
Bal 31 digestion of short stabilized VSG 121 and bR2 ES telomeres
Exonuclease Bal 31 attacks free ends. During a time course of Bal 31
incubation, stabilized terminal restriction fragments of VSG 121 (left panel)
and VSG bR2 (right panel) were liberated by EcoRI digestion and are
susceptible to Bal31 digestion (*) whereas chromosome-internal copies
are resistant (arrowhead)

Over time, the average length of the terminal fragment did not change significantly,
but the band became more heterogeneous (compare Figure 26D, week 16 and 29).
Upon further culturing, telomere stabilization also occurred on chromosome arms
harboring VSG 224 and VSG 1.8.
To confirm that the stabilized short chromosome ends remained terminal and did not
fuse with other chromosome arms, we treated the DNA with the exonuclease Bal31,
after which the DNA was cut with EcoRI to liberate terminal restriction fragments
that could be visualized with VSG probes (Figure 27). Telomere-linked copies of VSG
121 and VSG bR2, regardless of whether they were stabilized or not, were highly
susceptible to Bal31 treatment (Figure 27, asterisks), indicating that they remained
terminal. Non-telomeric copies (arrowheads) were unaffected by Bal31. Telomerasedeficient S. pombe can survive by circularizing their chromosomes (197).
Circularized chromosomes migrate slower during Rotating Agarose Gel
Electrophoresis (RAGE) separation (243). Using VSG 121 and bR2 as hybridization
probes, we verified that the chromosomes harboring these VSG remained linear and
VSG 121 and bR2 did not recombine onto other chromosomes (data not shown).
Taken together, telomere length analyses of different chromosome arms over several
months indicated that, upon reaching a critical length, terminal restriction fragments
were stabilized by a telomerase-independent mechanism. This mechanism seems to
act exclusively at critically short telomeres, since longer telomeres continued to
progressively shorten. Such a distinction has not been observed in other species in the
absence of telomerase.

Cloning and sequencing of short stabilized telomeres
To address whether short stabilized chromosome arms still contained telomeric
repeats or whether they were maintained by amplification of subtelomeric sequences,
short stabilized VSG 121 chromosome ends were cloned and sequenced using a
telomere tailing method (244). PolyC tails were added to purified ~2kB terminal
restriction fragments (previously isolated from agarose gels) using terminal
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Tailing of short stabilized terminal restriction fragments (TRF)
A) BglI restriction fragments, representing the stabilized VSG 121 TRF were isolated
from an agarose gel and tailed using terminal transferase and dCTP.
121 chromosome termini specific fragments were PCR amplified using primers A and B.
B) Incorporation of radiolabeled dCTP into BglI TRFs verified the efficiency of the tailing
reaction. Tailed products were run on a 1.8% agarose gel, the dried gel was exposed
to a phosphoimager. Labeled TRFs are indicated by the arrowhead, excess
unincorporated nucleotides migrate on the bottom of the gel. Optimal incorporation
efficiency was obtained by using 4.5 units / reaction.
C) PCR amplified products of tailed TRFs on agarose gel (see arrowhead). High cycle
number leads to unspecific products, thus non-tailed TRFs were used as negative control.
The indicated PCR product was gel purified and subcloned into pGEM-T.
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Figure 29
Cloning and sequencing of stabilized tailed terminal restriction fragments
A) Restriction analysis of individual clones showed the differently sized PCR
products, confirming the size heterogeneity observed on southern blots.
B) Sequencing of individual clones revealed that chromosome termini
are capped by telomeric repeats. The number of perfect hexameric
repeats varied from as little as 7 up to 27. The terminal nucleotide varied
between individual clones (TTAGG, T, TTA or TTAGGG). Sequences
shown are representative of 17 sequenced clones. By comparison with
wild-type DNA, no changes occurred in the subtelomeric region of VSG 121.

transferase. VSG 121 (primer A) and polyG primers (primer B) were used to PCRamplify the region encompassing the 3´ end of the VSG 121 ORF, the subtelomeric
region, and the end of the chromosome (Figure 28A). We verified tailing of purified
2kB terminal restriction fragments by measuring the incorporation of radiolabeled 32P-dCTP (Figure 28B). Maximum incorporation of radiolabeled dCTP was achieved
by using 4.5 units of terminal transferase. Thus, we were confident that we obtained
optimal conditions for the tailing reaction. Next we used primers A and B to PCR
amplify the region between tail and VSG 121. The high cycle number led to the
amplification of unspecific PCR products. To identify tailing specific products, we
ran non-tailed (-) PCR reactions in parallel on the agarose gel (Figure 28C). Tailing
specific PCR products were ligated into a cloning vector and analyzed by restriction
digest and sequencing. The amplified products varied in size among the clones
(Figure 29A). Sequencing of 17 clones (representative sequences are shown in
(Figure 29B) revealed terminal TTAGGG-repeat tracts that ranged from 41–200 bp,
reflecting the size heterogeneity observed by Southern blot (Figure 26). To further
confirm that no changes occurred in the subtelomeric region, we PCR amplified this
region in wild-type cells, using VSG 121 and (CCCTAA)5 primers. Comparison of
wild-type to mutant cells showed that no amplifications or rearrangements occurred
in the ~200 bp subtelomeric region between the VSG and the TTAGGG repeat tract.
The very end of the sequence varied between individual clones (Figure 29B). By
adapter cloning of telomere ends, it was previously shown that T. brucei telomeres
terminate in TTAGGG (213). This and other work suggested that the templating
region of telomerase RNA ends in AATCCC-5´ (209). The difference of terminal
sequence that we observe at short stabilized telomeres suggests that the mechanism of
telomere stabilization is independent of telomerase RNA. In conclusion, our results
suggest that a potentially novel mechanism maintains 41–200 bp of terminal
TTAGGG repeats in the absence of telomerase.

76

Does telomere length affect ES silencing?

Transcriptionally silent ES are subject to a telomere position effect (49), but it is not
known whether a silent ES can become transcriptionally activated if telomeres
become very short. To address this question, we measured silent ES VSG 121 and
bR2 transcripts by northern blot as telomeres became critically short and stabilized.
VSG 121 and bR2 transcripts remained undetectable during this time. Furthermore,
these
cells continued to stably express the initial VSG (Figure 30). These preliminary
results suggest that progressive telomere shortening and subsequent stabilization does
not lead to transcriptional activation of silent ES. In a previous study, an entire ES
lacking telomeric repeats, located on a circular bacterial artificial chromosome, was
transfected into T. brucei. ES promoters of these constructs remained transcriptionally
silent, suggesting that telomeres are dispensable for ES silencing (245).

Discussion

Telomere shortening led to loss of many of the apparently non-essential MC, and to
rearrangements among IC. MBC remained stable. Several possibilities could account
for these differences. Loss of MBC, which contain essential genes, would presumably
be lethal. IC only appear to contain ES, which can be active or silent, so
rearrangements or loss may be tolerated to some degree. MBC and MC exhibit
notably different positional dynamics during mitosis: MC associate directly with the
leading edge of the mitotic spindle whereas MBC lag behind and are partitioned by
classical kinetochore microtubules (246-248). Segregation of MC normally occurs
with high fidelity, as shown by their stable inheritance over 5 years of propagation,
but it remains unclear how the large number of MC are faithfully replicated and
segregated on one mitotic spindle (20). We suggest that MC may be attached to the
mitotic spindle through their telomeres. As a consequence of dramatic telomere

77

Weeks:

1

4

6

8

10

15

20

30

bR2

VSG 221
VSG bR2
Ethidium
Bromide

Figure 30
Northern blot: telomere stabilization does not lead to ES activation.
mRNA was isolated periodically for 30 weeks during which the VSG bR2
telomere stabilized.
Upper panel: Northern blot analysis demonstrates that VSG 221 remains actively
expressed.
Middle panel: Re-hybridization of the same blot with a VSG bR2 probe indicates
that the bR2 expression site did not become activated during telomere stabilization.
A positive control for VSG bR2 is in the far right lane.
Lower panel: Ethidium Bromide ensures equal loading between lanes.

shortening, spindle attachment becomes unreliable, so MC can be mis-segregated and
give rise to cells lacking a particular MC, or containing extra copies. During
successive rounds of replication, cells harboring extra MC might require slightly
more time to replicate. During 2.5 years, a minute replication disadvantage could
favor the survival of cells with fewer MC. A comparable situation has been observed
between different types of survivors in telomerase-deficient S. cerevisiae. Type I
survivors, which maintain their chromosome ends by extensive amplification of
subtelomeric Y´ elements have impaired viability and are usually outgrown by Type
II (telomere-telomere recombination) survivors. Extensive amplifications of Y´
elements (10% increase in genome size) increases the time needed for replication and
could result in the observed growth disadvantage (238).
The different segregation properties of MC and MBC might be comparable to a wellstudied phenomenon in S. pombe, where mitotic chromosome segregation depends on
centromeric sequences but, during meiotic prophase, chromosomes are aligned
through an oscillatory back and forth movement called the horsetail stage (249).
During meiotic prophase, the spindle pole body associates with telomeres (250).
Deletion of Taz1, a telomere-binding factor, leads to deficient telomere clustering and
meiotic recombination (251). Similarly, pedigree analysis of artificial
minichromosomes in budding yeast demonstrated that telomeric sequences
dramatically enhance faithful segregation to mother and daughter cell (252,253).
Short MBC telomeres stabilized as they reached a length of ~41–200 bp. Bal31
digestion confirmed that these short telomere tracts were indeed terminal and that
stabilized chromosomes did not fuse. 41–200 bp of telomeric repeat are sufficient to
stabilize a chromosome end. The size of 40 bp possibly reflects the minimal amount
of sequence needed for binding of one or two TRF dimers, which are necessary for
telomere protection (168,230). The terminal nucleotide varied between different
clones, indicating that telomere stabilization is independent of the telomerase
template RNA. Importantly, our data suggest that telomere stabilization is sufficient
to ensure genomic integrity of MBC in a large majority of cells, since there was no
discernable impact on long-term population growth. Nevertheless, T. brucei might
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have an enhanced propensity to undergo homologous recombination, similarly to sir /
tlc deficient yeast that become survivors without going through crisis (254).
We monitored telomere loss at several MBC and IC silent ES during 2.5 years. Silent
telomere shortening occurred at a constant rate of 3–6 bp/PD, and we did not observe
any telomere-telomere recombination. We did not detect extrachromosomal telomeric
circles, which could explain why short telomeres remained stable, during several
months of continuous culture, and did not undergo the dramatic telomere elongation
observed in human ALT cells and Type II survivors of S. cerevisiae (194,237,238).
Immortal human ALT cells are characterized by increased telomere length and
telomere heterogeneity, and the presence of extrachromosomal telomeric circles and
ALT-associated PML bodies (198,200,201,255). There is evidence that
telomere–telomere recombination accounts for the increase in telomere length in ALT
cells (199). It has also been suggested that extrachromosomal telomeric circles could
serve as a template for rapid rolling-circle-based elongation of telomeres
(108,199,256). However, telomere FISH on metaphase nuclei of ALT cell lines
shows many chromosome arms with little or no telomeric signal (257). The lack of
subtelomeric marker genes in ALT cells has hampered efforts to follow the fate of
individual telomeres. A recent report identified a human ALT cell line that maintains
short yet stable telomeres in the absence of characteristic ALT markers (258). In this
cell line, the average telomere length was ~5 kb, as assessed by telomere blotting of
RsaI / HinfI digested genomic DNA. The precise subtelomeric location of the RsaI
and HinfI sites are unknown, but the size of individual telomeres could be shorter
than 5 kb. Could the mechanism that stabilized telomere length in this cell line be
similar to the mechanism that stabilizes T. brucei telomeres as short as 40 bp?
Telomere stabilization has also been suggested to occur in Type I survivors in yeast,
where the chromosome terminus is capped by roughly 50 bp of telomeric repeats,
which remain at a stable length during subsequent rounds of replication (E. Louis,
personal communication).
We propose a speculative model that would restrict the extent of telomere elongation
and lead to the telomere stabilization that we observe. During telomere stabilization,
the 3´ telomere terminus could invade another short telomere by homologous
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A speculative model for telomerase-independent telomere stabilization.
Inter-strand break-induced replication: a conventional DNA polymerase
could extend the invaded 3´ end, using the C-rich strand of another telomere
as template. Extension might be limited by the 5´ end of the template short telomere (1).
Alternatively, T. brucei could have a machinery that tightly limits elongation of the 3´
terminus to 40–200 bp and give rise to telomere stabilization (2).Lagging strand
synthesis (in red), could result in a limited extension of short telomeres.

recombination. A conventional DNA polymerase could extend the invading 3´ end
through intra-strand break induced replication (Figure 31). Subsequent (or
concomitant) lagging strand synthesis would complete replication. The extent of
elongation would be limited by the size of the invaded telomere. If the majority of
telomeres are short, elongation would be restricted and could lead to telomere
stabilization (Figure 31A). Alternatively, inter-strand break-induced-replication in
conjunction with machinery that tightly controls elongation to 40–200 bp, could
facilitate telomere stabilization in the absence of telomerase (Figure 31B).
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Chapter IV: Complementation of TERT-deficient T. brucei
Introduction

In human and yeast cells, telomerase activity is tightly regulated by proteins that relay
information about telomere length (164,171). The ability of telomerase to extend a
telomere is inversely proportional to the initial length of the telomere DNA repeats
(162,163,173). This protein-counting model explains how short telomeres can be
rapidly elongated whereas the length of long telomeres is restricted (162). Having
short telomeres, at silent and active ES, enabled us to study telomere elongation
dynamics upon re-introduction of telomerase into T. brucei.

Results

We complemented telomerase-deficient mutants by introduction of wild-type TERT
and different telomerase fusion constructs: N-terminally HA-tagged TERT and Cterminally GFP-tagged TERT. All constructs were integrated into the rDNA spacer
region under a tetracycline-inducible T7-promoter (Figure 32) (259). To assess the
functionality of each construct, we transformed telomerase-deficient cells, and
measured the rate of telomere elongation at the active VSG 221 ES under full
tetracycline induction. Wild-type TERT efficiently elongated the truncated VSG 221
telomere whereas HA-TERT did not (Figure 32A and B). A TERT-GFP fusion
construct was functional and led to rapid elongation of a short active ES telomere
(Figure 32C).
Rates of telomere elongation at transcriptionally silent and active ES
Previous studies showed that an artificially seeded short telomere at the
transcriptionally active ES was rapidly elongated by telomerase (231). To determine
the rate of elongation at naturally shortened stabilized telomeres, and to verify that
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Complementation of telomerase-deficient mutant parasites.
A) Introduction of wild-type telomerase orf (under tetracyclin-inducable T7
promoter) results in elongation of active ES VSG 221 telomere.
B) Introduction of (HA)3-tagged telomerase did not result in elongation of
the active ES VSG 221 telomere.
C) Complementation with TERT-gfp tagged telomerase leads to rapid
elongation of the short active ES VSG 221 telomere.
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Telomere elongation dynamics at active ES
Telomere length prior to complementation is indicated by arrowheads.
Time in continuous culture is indicated on top in PD, rates of elongation
on the bottom of each panel.
A) Both panels: short active VSG 221 ES telomere were rapidly
elongated. As the telomere reached a length of ~8.5 kB, the rate
of elongation decreased.
B) Elongation of a 6.5 kB active VSG 224 ES telomere.
During the initial 110 population doublings, the rate of telomere
elongation was ~25 bp / PD. As the telomere reached a length of
9-10 kB, the elongation rate decreased to ~ 6.5 bp / PD.
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Figure 34
Telomere elongation dynamics at silent ES
The telomere elongation rate was determined at transcriptionally silent ES telomeres
of varying length (arrowheads).
A) B) and C) Elongation of three short stabilized silent ES telomeres (VSG 224,
121 and bR2) upon telomerase complementation. The rate of telomere elongation
is constant and ranges from 5.7 bp / PD to 7.5 bp / PD.
D) The rate of telomere elongation at silent ES is constant and independent of
telomere length. Upon complementation, two ES-linked copies of VSG 1.8, with
differing telomere length, are elongated at the same rate of 6 bp / PD (see also
panel C).
E) and F) Constant telomere elongation at long silent expression site telomeres
in wild-type T. brucei. Long VSG bR2 and 121 telomeres continuously elongate
at a constant rate.

these short telomeres could be extended by telomerase, we restored TERT to cells that
had been in culture for ~2.5 years and studied the dynamics of telomere elongation.
As shown in Figure 33A, a short 3.5-kb terminal restriction fragment containing the
actively transcribed VSG 221 and less than 1 kb of telomeric repeats was rapidly
elongated. The rate of elongation, measured from the initial day of complementation
to the first possible time point at which sufficient DNA could be obtained from the
cells (PD 28), was ~160 bp /PD. This experiment was repeated on six independently
complemented clones with similar results, so we are confident the rapid elongation is
a consequence of telomerase restoration rather than random recombination in
individual clones. We then re-introduced TERT into a clone that had a ~5 kB telomere
(terminal restriction fragment of 6.5 kB) at the active ES. Initially telomeres rapidly
elongated at a rate of ~25 bp/PD. When the elongated telomere reached 8–10 kb, the
rate of elongation decreased to ~6–8 bp/ PD (Figure 33B). Although the resolving
power of an 0.8% agarose gel is limited as telomere restriction fragments became
large, the elongation rate slowed down and remained at ~6.5 bp / PD for the last 7
weeks of the time course. Thus, when telomerase was restored to clones having
different telomere lengths at the active ES, the rate of telomere elongation was
inversely related to initial telomere length. Although preliminary, we noted that the
extent of rapid elongation might be more pronounced at short telomeres. As an
example, in the right panel of figure 33A, the long ~9kB telomere continuous to
elongate at a high rate whereas the elongation rate at the ~8kB telomere in figure 33B
is clearly lower. We do not know what causes this discrepancy and have not
investigated this further.
In contrast, the rate of elongation at transcriptionally silent telomeres was only 6–8 bp
/ PD when telomerase was restored, regardless of their initial length (Figure 34).
Telomeres harboring VSGs 224, 121 and one copy of VSG bR2 were short (40–200
bp) and stable, prior to reintroduction of telomerase (Figure 34A, B and C). The same
extension rate was observed at the larger of the two VSG bR2 telomeres (Figure 34C)
and at two longer telomeres of ~5.5 kb and 2.5 kb, harboring VSG 1.8 (Figure 34D).
Over 20 years ago, it was observed that T. brucei telomeres of 5–9 kb grow at a
constant rate (202,203). We wondered whether, in accordance with the conventional
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protein-counting model of telomere length homeostasis, elongation would cease when
a telomere reached a specific length. To address this question, we turned to
extensively propagated wild-type T. brucei and found that silent ES telomeres longer
than 10 or 15 kb continue to grow at a rate of 6–8 bp /PD (Figure 34E and F).
In conclusion, very short transcriptionally silent and active ES telomeres have very
different elongation dynamics. Short active ES telomeres are very rapidly elongated
by telomerase. As telomere length increases, the rate of elongation decreases to 6–8
bp / PD, as at silent ES.

Discussion

Short stabilized telomeres in telomerase-deficient T. brucei enabled us to study
telomere length regulation upon re-introduction of telomerase. Telomere length
regulation has been studied in numerous organisms. In human cells, telomere length
homeostasis is regulated by a negative feedback loop, executed through numerous
telomere-binding proteins that relay information about telomere length to the
telomere terminus (260). How these proteins accomplish this task remains unclear,
but recent work suggested that chromatin remodeling (or t-loop resolution) could
regulate telomerase access to telomere termini (164). However, this protein-counting
model apparently does not appear to apply to T. brucei, where transcriptionally silent
telomeres were elongated at the same rate, regardless of their initial telomere length.
Furthermore, during in vitro culture, telomere homeostasis is not achieved even at
long telomeres and they appear to grow indefinitely. This result implies that the
negative feedback loop that regulates telomere length in other organisms is absent
from transcriptionally silent telomeres in T. brucei.
We subsequently studied telomere elongation dynamics at short transcriptionally
active ES. In contrast to silent ES, a short active ES telomere was elongated at ~160
bp /PD. As the length of an active ES telomere increased, the rate of elongation
decreased until it matched the rate at silent ES. A summary of these results is depicted
in Figure 32A. The only known difference between active and silent ES is
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Figure 35
A) Summary of telomere elongation results. Short active ES telomeres are rapidly
elongated by telomerase. Silent ES telomeres elongate at a constant rate, regardless
of their initial length.
B) Model for telomere length regulation in T. brucei.
Left panel: silent ES telomeres: telomere termini are tucked away forming a t-loop
structure. During a particular stage of the cell cycle, t-loops are resolved, telomerase
accesses the short 3´ overhangs and adds 6–8 bp ending in TTAGGG. Elongation occurs
at the same rate regardless of initial telomere length.
Right panel: short active ES telomere. VSG transcription extends into the telomere,
disrupts chromatin structure (such as a t-loop) and allows telomerase unrestricted access
to the 3´ terminus. At long telomeres, transcription does not reach the telomere end,
allowing the telomere terminus to assemble into a telomerase-inaccessible structure.
As a consequence, the rate of extension decreases to levels comparable with
transcriptionally silent telomeres.

transcriptional activity, and it has been shown that transcription extends into
telomeric repeats (261). Recently, a direct correlation was demonstrated between the
strength of an inserted subtelomeric promoter and the rate of telomerase-dependent
extension at the adjacent short seeded telomere (50). Based on all these observations,
we propose a model in which transcription disrupts telomeric chromatin and enhances
telomerase access and elongation (Figure 32B). After rapid elongation, transcription
no longer reaches the telomere terminus, which can now reassemble into a t-loop,
rendering the 3´ end inaccessible during most of the cell cycle. Its elongation
dynamics now match those of transcriptionally silent ES.
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Chapter V: Consequences of telomere shortening at the active expression site

Introduction
We previously demonstrated that telomerase-deficiency led to progressive telomere
shortening at a rate of 3–6 bp/PD, MC loss, and genomic rearrangements among IC
(Chapter II and III). At essential MBC, silent ES telomeres stabilized within a
discreet size range by a potentially novel telomerase-independent mechanism.
In this chapter, we address the consequences of telomere shortening at the actively
transcribed VSG ES. In the absence of telomerase, this telomere progressively
shortens and breaks. Telomere breakage enabled us to rapidly obtain clones with very
little telomeric DNA at the active ES and study the consequence of a short telomere
on VSG transcription.

Results
Telomere breakage and shortening at the active VSG 221 expression site
Telomere length changes at the active VSG 221 ES can be visualized by digestion
with EcoRI and hybridization with a VSG 221 probe (Figure 36A). The actively
transcribed ES telomere is subject to frequent terminal deletions (202-204). These
truncations and their subsequent repair by telomerase account for the telomere length
heterogeneity we and others have observed at the active ES in wild-type cells (Figure
36B) (231). Although VSG 221 signal is heterogeneous, it remains within a high
molecular size range (>10 kB) throughout the time course (Figure 36B).
In telomerase-deficient cells, these breaks cannot be repaired, leading to dramatic loss
of telomeric DNA at the active V S G 221 ES (Figure 37A). In a newly cloned
population, the active ES VSG 221 terminal restriction fragment is present as a sharp
band (Figure 37A, upper panel, week 0). During subsequent culturing, and as a result
of telomere breakage, the signal starts to smear towards the bottom of the gel. To
verify equal loading and to confirm the progressive moderate shortening at silent ES,
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the blot was re-hybridized with a probe against a silent VSG bR2 (Figure 37A, lower
panel). We quantified the extent of telomere loss at the active ES over 8 weeks by
measuring signal intensity in each lane as a function of telomere length (Figure 37B).
In several independent experiments the distribution of telomere signal changed
reproducibly over time, suggesting that telomere breakage occurred at a constant rate.
By measuring total VSG 221 signal in each lane and comparing it with the intensity of
time 0 signal, we observed a dramatic decline in VSG 221 signal during the last weeks
of the time course (Figure 37C). Northern blot analysis revealed that VSG 221 signal
loss coincided with a decrease in VSG 221 transcript levels (Figure 37D, upper
panel). Upon reprobing of the blot with various VSG probes, we noted a gradual
increase in VSG 1.8 transcript levels over time (Figure 37D, middle panel). By the
end of the time course, the population expressed roughly equal amounts of VSG 1.8
and VSG 221, as judged by northern blot. We also isolated mRNA from the
population and amplified VSGs by RT-PCR. Through subcloning and sequencing of
30 clones, we verified a VSG 221 : VSG 1.8 ratio of 1:1. No other VSGs were
amplified during this experiment.
We investigated the events that led to VSG 1.8 activation, by analyzing 11 VSG 221negative clones by PFGE (Figure 38). Unfortunately, under the conditions used, the
silent copy of VSG 1.8 is not well separated from VSG 221 and we could not formally
prove whether VSG 1.8 was replacing VSG 221 in the transcribed ES (Figure 38).
This result led us to investigate further the consequences of a short telomere at an
active ES.
Telomerase-deficient cell lines cannot repair telomere truncations, which allowed us
to select clones that had lost large amounts of telomeric DNA from the active ES. Six
telomerase-deficient clones that had undergone active ES telomere truncations are
shown in Figure 39A. Clones with very short telomeres, notably clones 1, 2, 3 and 5,
were only obtained after several rounds of continuous propagation and cloning, and
we focused our attention on these. The sequence between the VSG 221 and its
telomere is known, and indicates that a ~3 kb terminal restriction fragment contains
~200–400 bp of telomeric repeats (Figure 36A) (231). As judged by northern blotting,
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Figure 36
Telomere breakage and elongation at active ES in wild-type T. brucei
A) schematic representation of the VSG 221 ES.
EcoRI site is located between 70-bp repeats and VSG 221.
Black bar underneath VSG 221 represents the hybridization
probe used in B.
B) Active ES VSG 221 terminal restriction fragment visualized by Southern blot.
Digestion: EcoRI, hybridization probe: VSG 221.
Left panel: active ES VSG 221 telomere length dynamics in
wild-type over 295 PD. Right panel: same experiment in parasites
heterozygous for telomerase.
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Figure 37
Telomere loss at active VSG 221 ES in telomerase-deficient T. brucei
A) Upper panel: EcoRI telomere terminal restriction fragment (TRF) hybridized with
VSG 221. Telomere shortening and breakage leads to loss of telomeric DNA at the
active ES and smearing of the 221 signal towards the bottom of the gel. Lower panel:
reprobing with silent ES VSG bR2 verifies equal loading. Schematic representation of
VSG ES are shown on the right.
B) Signal intensity distribution up to week 8 of panel A is graphically represented
as a function of telomere length. Smearing of the signal is apparent as peaks become
broader and move towards lower molecular mass.
C) Total VSG 221 signal in each lane over the 8 weeks time course as a percentage
of initial signal (lane 1).
D) Northern blot of 13-week time course shown in panel A. VSG 221 (upper panel)
transcripts level decreases over time and VSG 1.8 (middle panel) becomes activated.
+ controls for VSG 1.8 are in right 3 lanes. Equal loading verified by Ethidium
bromide staining (lower panel).
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Figure 38
Characterization of VSG switchers by PFGE and Southern blotting
11 switched clones, a telomerase-negative "parental" clone and wild-type are indicated
above each lane. Size markers are shown on the left of each panel.
A) Left panel: Ethidium bromide stained RAGE gel. Right panel: Southern blot using
VSG 221 as a hybridization probe. VSG 221 is lost in 10 out of 11 clones. Since the
signal in clone 8 is weaker than in the parental cell line, we suspect it is due to crosshybridization.
B) Left and right panel: reprobing of the blot with VSG 1.8 and VSG bR2 probes,
respectively.

telomere lengths in this range did not affect VSG 221 mRNA levels at this time
(Figure 39B).

Gradual loss of VSG 221 over time

Next we determined whether further shortening of the active ES telomere would
occur, and whether it would affect the transcriptional status of VSG 221. We
addressed these questions by keeping three independent clones in continuous culture
for 15 weeks, during which we monitored population growth and isolated DNA and
RNA every week. The short active VSG 221 ES terminal restriction fragment was
slightly heterogeneous and ended in ~200–400 bp of telomeric DNA, but did not
shorten further (Figure 40A, upper panel, arrowhead). In contrast to silent ES
telomeres, however, the VSG 221 probe signal in the active ES gradually decreased
during the initial 5 weeks (Figure 40A). To ensure equal loading between each lane
and to confirm that longer silent ES telomeres continued to shorten, the membrane
was re-probed with silent ES VSG bR2 and VO2 (Figure 40A, middle and lower
panel). As anticipated, the two ES-linked copies of VSG bR2 and the single telomeric
copy of VO2 (arrowheads) progressively shortened at a rate of 3–6 bp/PD. We also
observed that short active ES telomeres occasionally elongated, presumably through
recombination with another telomere (will be discussed later).
The loss of the VSG 221 gene poses two threats to the cell. First, the parasite needs a
protective surface coat for survival. Secondly, loss of the VSG 221 gene and its
telomere results in an unprotected chromosome end that probably requires repair.
Since we did not detect any growth retardation, we were interested to learn how the
cell addressed these problems. RNA analysis of clone B confirmed that VSG 224
became dominant in the population as VSG 221 transcript levels diminished (Figure
40B, left 4 lanes). Two other independent clones (A+C) lost VSG 221 over a period of
~ four to five weeks and also activated VSG 224 (Figure 40B, right 3 lanes).
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Selection for clones with a short active VSG 221 ES telomere.
A) Telomerase-deficient clones cannot repair telomere truncations
and yield clones with varying active-ES terminal restriction fragments
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Figure 40
A short telomere at the active ES leads to loss of the transcribed VSG
A) VSG 221 loss in 3 individual telomerase-deficient short active ES
telomere clones (A, B and C) during 9 weeks of continuous propagation.
The size of the predominant VSG 221 band does not change over time,
but signal intensity decreases, reflecting loss of the gene. Probes for
silent ES VSG bR2 and V02 (arrowheads) confirmed their stability and
shortening, and verified equal loading.
B) RT-PCR shows that VSG 224 transcripts replace VSG 221. Interestingly,
all three clones activated the same VSG (far right 3 lanes).

VSG 224 replaced VSG 221 in the active expression site

To clarify the events that led to VSG 224 expression, we generated a ~9-kb SmaI
terminal restriction fragment that hybridized with both VSG 221 and an upstream
VSG pseudogene (Figure 41). At four weeks of continuous culture, VSG 221 was
present as a smear and subsequently again lost from the population. We speculate that
breaks within or downstream of VSG 221 could lead to partial recombination
intermediates that are not properly resolved (due to lack of homology) and migrate
slower on an agarose gel. By week 8, the size of the predominant restriction
fragments containing the pseudogene increased to ~23 kb (Figure 41A, middle panel,
asterisk) and co-localized with a new copy of VSG 224 (Figure 41A, right panel,
asterisk), suggesting that VSG 224 and part or all of its associated telomere replaced
VSG 221 at the previously transcribed ES. The silent copy of VSG 224 is marked with
an arrowhead. In addition to the ~23 kB bands, a higher molecular band appears that
does not co-localize with the pseudogene (arrow). We attribute this band to individual
breaks in which the SmaI site and the pseudogene marker were deleted. Deletion of
the pseudogene occurred after 8 weeks in two analyzed clones, as the duplicated copy
of VSG 224 appeared (Figure 41B and C, arrow). To determine whether VSG 224
was activated by gene conversion or reciprocal translocation, we separated whole
chromosomal DNA. In all three clones, VSG 221 was lost after 4 weeks and VSG 224,
initially present as a single copy gene, was duplicated into the ES that previously
carried VSG 221 (Figure 42A).
We independently confirmed that the ES was unchanged, using a blasticidin
resistance gene that we had integrated immediately downstream of the active ES
promoter, while VSG 221 was being expressed (23). No drug selection was applied
during propagation and switching, but the cells retained the marker and were highly
resistant to blasticidin, indicating that the same ES was in use (Figure 42B).
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VSG 224 replaces VSG 221 at the active ES, based on restriction digest and
genomic blotting.
A unique upstream pseudogene probe (schematic representation on the right) was
used to demonstrates that VSG 224 replaced VSG 221 in the same active ES.
A) Left panels: as shown in Figure 37, the population lost VSG 221 by 8 weeks.
Middle panel: reprobing of the blot with an ES-specific pseudogene probe.
After VSG 221 loss, the size of the predominant terminal restriction fragment
increases to ~23 kB (asterisk). Right panel: reprobing with the newly expressed
VSG 224 probe. VSG 224 signal appeared after VSG 221 loss and colocalized precisely with the pseudogene signal (asterisk), indicating that
VSG 224 translocated into the ES, previously occupied by VSG 221.
An arrowhead marks the silent copy of VSG 224. Arrow and asterisk indicate
different means of VSG 224 activation within the population (see below).
B) and (C) In two other clones, pseudogene, the SmaI site and VSG 221
were lost (left and middle panel). Duplicated copy of VSG 224 is indicated
by an arrow (right panel).
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VSG 224 replaces VSG 221 at the active ES: Rotating Agarose Gel Electrophoresis
Chromosomal DNA separation by RAGE confirms that VSG 224 replaced VSG 221
at the active ES through a duplicative gene conversion event.
A) Upper panel: VSG 221 is lost by week 8. Lower panel: reprobing with VSG 224
shows that VSG 224 replaces VSG 221 on the same chromosome. Under the conditions
used, the ~3.2 Mb chromosome VI band, harboring the 221 ES, is well separated from
other chromosomes. (+) indicates VSG 221 positive controls.
B) Top panel: ES integrity was verified by the retention of the blasticidin resistance
marker (BSD) that was inserted immediately downstream from the ES promoter. All
three clones retained BSD and were highly resistant to blasticidin. Switch lane represents
a switched clone from a previous experiment; Parental is the telomerase-deficient cell
line without BSD at the active ES, WT is wild-type. Middle panel: as in the panel A,
VSG 221 is lost after 4 weeks of continuous culture.

Could a short telomere trigger an antigenic switch?

Due to the low switching frequency and apparent growth advantage of VSG 221expressing cells in vitro, our cell lines rarely lose VSG 221 or otherwise result in
another VSG becoming dominant in the population, even after extensive propagation.
Hence the appearance of a new VSG at the active ES locus was unexpected and could
be explained in two ways. As telomere length at the active ES becomes very short,
telomere breakage could lead to terminal truncations and gradual death of the VSG
221-expressing cells in the population. Switched cells, which normally arise at a low
frequency, would progressively outgrow the dying cells and lead to the dominance of
a new VSG in the population. Alternatively, telomere breaks could be repaired by
break-induced replication (BIR) facilitated by other telomere-linked VSG, with a
possible consequent increased rate of antigenic switching.
To address these questions, we attempted to measure switching frequency of strains
with a short active ES telomere by using immune-selection in mice. However, due to
extensive propagation in laboratory culture, or unforeseen consequences of short
telomeres in an animal infection that were not evident in culture, these strains did not
grow well in mice. Re-adaptation to mice, during three weeks of sequential transfer,
appeared to select for recombination-based elongation of the active ES telomere
(Figure 43).
In collaboration with Doeke Hekstra from Stanislas Leibler’s laboratory, we made a
mathematical model to predict the growth dynamics of a culture if a short telomere
leads to gradual lethality and switchers arise at various frequencies (10-3–10-6).
Gradual death of cells with a short active ES telomere and concomitant appearance of
switchers (at a rate of 10-6, but with a growth advantage), would only subtly affect
population growth dynamics over 4–5 weeks. In conclusion, unless the switching
frequency is dramatically higher at short telomeres, switchers must have a clear
growth advantage in order to outgrow the population within 4 weeks. However, we
had to assume parameters such as relative fitness of short telomere strains and growth
advantage of switched parasites, for which we have no experimental data. Thus, we
cannot exclude the possibility that switchers, at a frequency of 10-6, could have
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Figure 43
Recombinational elongation of active ES during mouse adaptation
VSG 221 telomere length was monitored by EcoRI digestion and hybridization
with a VSG 221 probe. Lane "before mouse": Active ES VSG 221 telomere length
before inoculation into mice.
Lanes 1+2: VSG 221 telomere length after 1 and 2 weeks of passaging
in laboratory mice.
Lanes 3-6: 3 clones were picked after 3 weeks of passaging in mice.
VSG 221 telomere length increased, presumably due to recombination.

outgrown dying parasites without giving rise to a significant decline in population
fitness, which would mean that telomere break-induced repair did not necessarily
increase the switching rate.

Discussion

As with silent ES telomeres, the length of a short active ES telomere could be
maintained. However, in sharp contrast to stabilized silent ES telomeres, the actively
transcribed VSG 221 was gradually lost from the population and replaced by another
VSG through a duplicative gene conversion event. What could account for the
difference between silent and active ES? One conspicuous difference is that the active
ES undergoes frequent terminal truncations, which were observed many years ago
(82,202,203). Although the nature of these breaks remains unclear, they could be a
consequence of transcription bubble destabilization and / or nucleolytic degradation
as transcription reaches a DNA terminus. It has also been shown that stalled
replication forks can give rise to a double-stranded break (DSB) and subsequent
repair through BIR (239). It is possible that at a heavily transcribed chromosome end,
stalling occurs more frequently. At short telomeres, replication forks could stall
within the subtelomeric region; thus, we hypothesize that a truncation might
frequently fall within the subtelomeric region, resulting in a DSB. The DSB could be
repaired through BIR (Figure 44), a mechanism that has been well studied in S.
cerevisiae (262). During BIR, the centromere-proximal end of a break is processed
into a 3´ overhang, which can invade the sister chromatid and use it as a template for
repair. DNA-polymerase-mediated synthesis completes the repair (263). In T. brucei,
the repair template could be any ES or possibly just a VSG-containing telomere,
depending on the location of the break (Figure 44) (263), and BIR could extend into
the telomere, resulting in duplicative expression of a new VSG and seeding of a new
telomere. Depending upon the circumstances, BIR might not effectively repair every
active ES break: sometimes an entire ES might be deleted, resulting in an in-situ ES
switch or death (264). Although active ES deletion has been observed, the authors did
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not investigate how the chromosome end remained protected. One possibility is that a
telomere was seeded onto the broken chromosome end.
Thus, we speculate that telomere breakage at the active ES could accelerate VSG
switching. Due to overwhelming technical difficulties, we were unable to measure the
VSG switching rates in clones with short telomeres at the active ES, and
mathematical modeling could not exclude the possibility that, when short active ES
telomeres broke, VSG expression was compromised and these cells died. We could
not determine the telomere breakage frequency in the population and, if it were low,
VSG switches arising at the normal (for this strain) low frequency of ~10-6 /PD could
dominate the population within a period of 4–5 weeks without an observable pause in
population growth (74,82).
In conclusion, within a few weeks of continuous culture, the VSG at a short active ES
telomere in telomerase-deficient T. brucei is replaced by a new VSG through
duplicative gene conversion. Our observation could be explained if active ES
breakage caused a DSB and its subsequent repair through BIR. The majority of
antigenic switches in African wild-type isolates occur through duplicative gene
conversion and it remains to be determined whether active ES-restricted telomere
breakage is at least partly responsible for high rate of gene-conversion-mediated
antigenic variation (73).
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A model for VSG switching by Break-induced replication (BIR)

Chapter VI: Telomere length analysis in African wild-type strain isolates
Introduction

The rate of antigenic switching varies substantially among strains of T. brucei.
African wild-type isolates have a high switching frequency of ~10-2–10-4 /PD
(73,79,90,91). The high switching frequency of wild-type isolates is not suitable for
many laboratory studies. Thus, isolates were often subjected to rapid syringe
passaging, a procedure during which parasites are transferred sequentially in mice in
the absence of immune selection (90). After several months, such parasites become
monomorphic and more virulent, with higher parasitemias and as much as a 10,000fold reduction of switching frequency (74,75,82,90-92). Unfortunately, very little is
known about the molecular changes that occur during laboratory adaptation, nor what
mediates the reduction in switching frequency. Identifying these changes might
improve our understanding of antigenic variation and lead to the identification of
targets for therapeutic intervention.
To this point, all our results were obtained by using a telomerase-deficient cell line,
and we wanted to know whether these results could be relevant to telomeraseproficient wild-type trypanosomes. In other words, if short telomeres increase the
frequency of antigenic switching, rapid-switching wild-type isolates might have
shorter telomeres than monomorphic laboratory-adapted strains.
In this chapter we measured telomere length in fast-switching wild-type isolates,
recently laboratory-adapted strains, and extensively propagated laboratory lines. We
found that wild-type African isolates and recently laboratory-adapted strains have
dramatically shorter telomeres than extensively cultured strains. We also show that
telomere growth at a rate of 6–8 bp/PD appears to be a unique feature of antigenic
variation-proficient T. brucei and does not occur at such a rate in other kinetoplastid
parasites. We propose a model in which telomere length and breakage affect the rate
of antigenic switching, and telomere growth leads to stabilization of the active ES
telomere and the well-documented switch reduction associated with laboratory
adaptation.
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Results
Telomere length analysis in laboratory-adapted strains and recent wild-type isolates

Based on our experiments with telomerase-deficient cell lines, we suggested that
telomere shortening at the active ES might lead to an increase in the frequency of
antigenic variation. This notion led us to measure telomere length in wellcharacterized pleomorphic and monomorphic strains, and in other available wild-type
African isolates whose history was fairly clear. A summary of the lineages of the
analyzed strains is provided in Materials and Methods.
The telomeres of the four Lister 427-derived cell lines (only 150 and 501 are shown
in Figure 45A) are strikingly similar in length, ranging from 3–20 kB, with an
average of ~15 kB, as previously shown (101,265). Telomeres of African wild-type
isolates ranged in size from 3–12 kB, with an average of ~8–10 kB (Figure 45A,
compare lab-strains to African isolates). To quantify telomere length differences
between individual strains, we measured signal intensity within given size increments
as a function of total signal in each lane and graphically represented the results of this
analysis (Figure 45B, upper panel). The average signal distribution of laboratory
strains versus African wild-type T. brucei is shown in the lower panel of Figure 45B.
In laboratory-adapted populations that stably express one particular VSG, constitutive
elongation of all non-transcribed telomeres could account for this difference. To test
this hypothesis, we measured telomere length in another recently laboratory-adapted
strain, TREU927, used for the T. brucei genome project. As described elsewhere (92),
TREU927 clone 4 was passaged 39 times in mice to increase its virulence, and
predominately expresses VSG GUTat 10.1 (Figure 45C). Even after ~ 75 further
doublings as procyclic forms, our sample of TREU927 also has dramatically shorter
telomeres than the extensively in vitro cultured Lister 427 SM (Figure 45C). We
predict that stable expression of VSG 10.1 and continuous in vitro growth of
TREU927 would eventually lead to a strain with dramatically elongated telomeres.
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Figure 45
Analysis of telomere length in African wild-type isolates and laboratoryadapted T. brucei. Genomic DNA from laboratory-adapted strains and wild-type
isolates was digested with AluI /MboI and separated on a 0.8% agarose gel.
Telomere restriction fragments were visualized by in-gel hybridization using a
radiolabelled (TTAGGG)4 probe.
A) Lanes 1 and 2: Lister 427 RUMP150 and RUMP501 have long telomeres
(average ~15 kB). Lanes 3–7: wild-type African isolates (S42, 348, 151, 502
and 100) have shorter telomeres (average ~ 8–10 kB).
B) Upper panel: telomere size distribution as percentage of total signal intensity
(see Materials and Methods for details). Lower panel: average telomere size
distribution of two laboratory-adapted strains and five wild-type isolates.
C) Comparison of telomere length between recently laboratory-adapted
TREU927 and long-term laboratory cultured Lister 427 ‘single marker’.
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Telomere length difference between African isolates and laboratory-adapted strains
A) Direct comparison of telomere length between African wild-type isolate 502
and laboratory-adapted strain 501 by genomic blotting using RsaI, MboI, AluI
digested DNA and (TTAGGG)4 hybridization probe.
B) Telomere length comparison using BglI terminal restriction analysis of
the MITat 1.21 harboring chromosome. Left two lanes show telomere
shortening during a time course of telomerase-deficient cell line
identifying the ES-linked copy of MITat 1.21 (arrowheads). Left two
lanes: dramatic size difference between the ES-linked copy in Lab 501
vs. wild-type 502 (arrowheads). Lower band: no size changes occur at
the chromosome-internal copy of MITat 1.21.

A direct comparison between the only well-characterized rapid switching strain 502
and laboratory-adapted strain 501 is shown in Figure 46A. Using a terminal
restriction fragment that contains a unique subtelomeric VSG gene, we compared
telomere length at single chromosome resolution (Figure 46B). These strains contain
two copies of MITat 1.21 VSG, located at a telomeric ES and at a chromosomeinternal locus (Figure 46B). The MITat 1.21 containing terminal restriction fragment
gradually shortened in the absence of telomerase whereas the chromosome-internal
copy remained stable (Figure 46B, left panel, arrowheads). The ES-linked copy of
MITat 1.21 in 502 is dramatically shorter than in Lab 501 (Figure 46B, right panel,
arrowheads).

Telomere length analysis before and after laboratory-adaptation

Next, we studied bulk telomere length dynamics in two strains, STIB247 and
STIB386. Clones (STIB247L and STIB386AA) made soon after isolation of both
wild-type strains were pleomorphic, and laboratory-adaptation during 52 mouse
passages (roughly 5 months) gave rise to monomorphic lines that predominantly
expressed VSGs GUTat 8.1 and GUTat 9.1, respectively. Although we have no
information on their switching frequencies before and after lab-adaptation, the
relationship between these paired samples (their DNA was kindly provided by
C.M.R. Turner, Glasgow University) is not in doubt. Figure 47A shows telomere
Southern blots of DNA from the two strains, before and after lab-adaptation. The only
well-resolved bands are on the top of each lane and appear to elongate during
propagation (arrowheads). However, we cannot be certain that they represent the
same telomere pre- and post-adaptation. To address whether average telomere length
increased during laboratory-adaptation, we quantified telomere signal intensity as a
function of length. Telomere signal at higher molecular weight did increase somewhat
in 348 during laboratory-adaptation (Figure 47B, lower panel), but not during
adaptation of 247 (Figure 47B, upper panel). These results are difficult to interpret
and we do not know precisely what happens, but they could be explained if ES
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Figure 47
Telomere length changes during laboratory-adaptation of wild-type isolates
STIB247 and STIB386.
A) Southern blot of RsaI, MboI, AluI digested DNA from strains 247 and 386,
before and after 52 rapid syringe passages that led to stable expression of
VSGs GUTat 8.1 and 9.1 respectively. The well-resolved high molecular bands
(arrowhead) appear to elongate (although we cannot be certain that they
represent the same telomeres before and after adaptation).
B) Telomere length analysis as described for Figure 42B.
Telomere signal intensity was plotted as a function of telomere length.
Upper panel: pre- and post adaptation of strain 247.
Lower panel: pre- and post adaptation of strain 386.

rearrangements and /or VSG switches occurred frequently during syringe passaging,
leading to continuous rearrangements of telomeric DNA and no net increase of
telomere length. Furthermore, we do not know the precise doubling time of these
parasites and it is possible that during the elapsed time, telomere elongated only 6001000 bp, which may not be sufficient to cause a significant shift in overall telomere
signal. Telomere elongation has never been studied in wild-type African isolates, yet
there is no evidence that the elongation dynamics are different in laboratory-cultured
parasites. Furthermore, as we will discuss later, elongation of a single active ES
telomere could be sufficient to cause the presumed VSG switch reduction associated
with rapid serial passaging.

Telomere growth at a rate of 6–8 bp/PD appears to be a unique feature of T. brucei

T. brucei belongs to a highly diverged group of kinetoplastid protozoa that includes T.
cruzi and L. major, causative agents of Chagas’ disease and cutaneous Leishmaniasis
respectively (233). We wanted to know whether telomere growth is unique to
trypanosomes that undergo antigenic variation, exemplified by T. brucei. To address
this question, we kept L. major, L. tarentolae and T. cruzi in continuous culture for
four weeks. We isolated DNA at weekly intervals, digested it with MboI and AluI,
and determined telomere length by in-gel hybridization using a (TTAGGG)4 probe.
The majority of L. major telomeres ranged from 3–12 kB and, although minor
telomere rearrangements occurred, we failed to observe any constant telomere
elongation during this time course (Figure 48A, B). Next, we observed that different
isolates of L. tarentolae have different telomere lengths, ranging from 3–9 kB to
roughly 3–20 kB. Although, telomere length appears to increase slightly in strain Lt
77 the rate of elongation appears to be dramatically lower than in T. brucei.
Elongation at a rate of 6–8 bp/PD should result in, at least 500 bp extension of the
telomere tract (Figure 48B). To verify that the observed signal represented telomere
terminal restriction fragments, we incubated DNA from strain Lt 95 with the
exonuclease Bal31 for various times and subsequently digested the DNA with MboI
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Figure 48
Telomere length analysis in three other kinetoplastid protozoa
Telomere growth at a rate of 6–8 bp/PD appears to be unique feature of T. brucei.
Genomic DNA was isolated at weekly intervals over 4 week time courses
digested with MboI and AluI; telomere restriction fragments were visualized
by a (TTAGGG)4 probe. PD are indicated on the left.
A) L. major Friedlin strain telomeres range in size from ~2 to more than
12 kB. Minor rearrangements occur but no significant constant elongation of telomeres
is visible on this blot. Yet, 77 PD of continuous culture might not be sufficient to detect.
B) Telomere length varies in three different isolates of L. tarentolae
(from 3–9 kB to 3–20 kB) and no dramatic constant telomere elongation occurs.
Right lanes show two samples of L. major run on the same gel.
C) Telomeres of this T. cruzi isolate vary in size from 500 –1500 bp and during a
24 PD time course, no significant increase in telomere length can be observed.
The slower migrating band at PD 16 is due to partial digestion.
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Figure 49
Bal 31 digestion of L. tarentolae DNA
Time of Bal 31 treatment is indicated in minutes above each lane,
after which DNA was digested with MboI and AluI.
A) A radiolabled (TTAGGG)4 probe was used to visualize telomere
terminal restriction fragments by denaturing in-gel hybridization.
B) Ethidium bromide staining of the gel shown in panel A.

and AluI. As expected, Bal31 digestion diminished telomeric signal, indicating that
the restriction fragments were terminal (Figure 49). As reported previously, telomeres
of different T. cruzi isolates can vary in size from ~1–10 kB, but the question of
whether they grow has not been addressed (215). Telomeres of our Y-strain clone
were shorter than those of all other species and samples tested, and we could not
observe any telomere length change during 24 PD (Figure 48C).
However, as this work was completed we learned that Leishmania telomeres do in
fact elongate (P. Borst, personal communication). Yet it is unclear at what rate. This
discrepancy could be explained by the fact that we cultured these strains for 4 weeks,
which corresponds to only 77 and 24 PD for Leishmania and T. cruzi, respectively.
We anticipated telomere growth at a rate of 6–8 bp/PD and this time frame might be
too short to detect telomere elongation if it occurs at a lower rate. Furthermore, we
did not measure telomere elongation dynamics at single chromosome resolution.
Nevertheless, considering the limited interpretability of these results, they do suggest
that robust 6–8 bp/PD constant telomere growth is a unique feature of T. brucei. The
possible implications of these results will be discussed in chapter VIII.
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Chapter VII: Preliminary results on Mre11-deficient T. brucei
Introduction

Telomerase deficiency leads to progressive telomere shortening at a rate of 3–6
bp/PD. This rate correlates with telomere decline in telomerase-deficient S. cerevisiae
and the proposed shortening due to the end replication problem
(112,113,121,122,265).
With the exception of the active ES telomere, shortening occurs at a constant rate.
Silent ES telomere shortening was monitored over more than two years and,
strikingly, the terminal restriction fragment remained a sharp band. This was also
visualized by telomere blotting, where shortening of individual chromosome ends
was measured over time. Human telomeres, in contrast, are more heterogeneous and
telomere decline cannot be measured at single chromosome ends. The apparent
telomere length heterogeneity in human cells could be the consequence of nucleolytic
degradation and telomere rapid deletions (TRD) (201).
Invasion of upstream telomeric DNA by the terminal G-overhang can form a t-loop
structure. In both human and yeast, resolution of this structure by homologous
recombination can result in dramatic attrition of the telomere tract by TRD and the
appearance of circular t-loop sized molecules (200,201,266). Genetic studies revealed
that TRD depends on recombination pathways involving Rad52 and the tripartite
Mre11/Rad50/Xrs2 or Nbs1 complex (205). Furthermore, the rate of TRD can be
dramatically enhanced by overexpression of dominant-negative alleles of scRap1 or
hTRF2 (201,267). Judging by appearance on southern blots, the size heterogeneity at
the active ES telomere in T. brucei, where telomere truncations and repair by
telomerase occur, looks similar to human telomeres. Are active ES truncations a
result of TRD and dependent on Mre11 and / or other recombination proteins?
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Mre11-deficiency does not affect telomere length in T. brucei

An Mre11-deficient cell line was previously created in our laboratory and used to
investigate this question. T. brucei Mre11 is a non-essential gene, its deletion results
in mild growth retardation, impaired double-strand break repair and gross
chromosomal rearrangements (86,268). To address whether Mre11 plays any role in
telomere length regulation, Mre11-deficient cells were kept in continuous culture for
280 PD and DNA was isolated at frequent intervals (Figure 50). EcoRI digestion
released terminal restriction fragments that were visualized by sequential
hybridization with silent VSG bR2 and active VSG 221 probe (Figure 50A).
Expression-linked copies of VSG bR2 were not very well resolved on this blot, yet
taking the slight growth retardation of this cell line into consideration, the gradual
elongation rate did not appear different from wild-type cells (Figure 50, left panel).
The actively transcribed VSG 221 terminal restriction fragment was short, very
heterogeneous and elongated over time (Figure 50, right panel). After extensive in
vitro culture, several clones were picked from the population and active ES terminal
restriction fragment length was compared between Mre11- and TERT-deficient
clones (Figure 50B, right panel). VSG 221-containing fragments appeared slightly
more heterogeneous in Mre11-deficient clones than in their TERT-deficient
counterparts (Figure 50B, compare left and right panel). However, telomere length
varied between parental clone I and the two picked subclones II and III (Figure 50B).
The length heterogeneity observed between these clones is reminiscent of the
telomere breakage we observed in wild-type and TERT-deficient strains and suggest
that telomere breakage still occurs in Mre11-deficient cells.
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Figure 50
Telomere truncations still occur in the absence of MRE11.
A) left panel: Two ES linked copies of silent ES VSG bR2 gradually elongate
during a 280 PD time course (arrowhead). Right panel: same blot upon reprobing
with active ES VSG 221 probe. Length of active ES telomeres is very heterogeneous.
B) Telomere breakage at the active VSG 221 ES in TERT and MRE-deficient
T. brucei. Left panel: telomere length was analyzed in three clones of TERT-deficient
clones. Right panel: Lane I: parental strain and two derived clones (II and III).
Note that telomere length in MRE11-deficient clones appears slightly more heterogeneous.

G-overhang structure in Mre11-deficient T. brucei

In S. cerevisiae the Mre11-complex plays a role in establishing G-overhangs
throughout the cell cycle (120). To investigate whether Mre11 plays any role in Goverhang maintenance in T. brucei, whole chromosomes of wild-type single marker,
KU-, Mre11 and TERT-deficient cell lines were analyzed by PFGE-overhang assay
(Figure 51). Duplicate native gels were hybridized with (TTAGGG)4 and (CCCTAA)4
probes (Figure 51, upper panels). A robust G-overhang specific signal was detectable
on concentrated MC and equal loading was verified by denaturation and rehybridization with the same probes. The experiment depicted in figure 51 requires to
be repeated several times and G-overhang signal intensity must be quantified by
phosphoimager, in order to elucidate, whether tbMre, tbKU or tbTERT are involved
in G-overhang maintenance.

Discussion
In human and S. cerevisiae, the Mre11 complex is involved in TRD (201,205). We
attempted to investigate whether T. brucei Mre11 is involved in the terminal
truncations, we and others have observed at the actively transcribed ES telomeres
(82,202,203). Our results suggest that tbMre11 is not involved in telomere length
regulation nor telomere terminal truncations. The observed smearing of terminal
restriction fragments could be the result of cell death in the population. Mre11deficiency results in growth retardation, yet no delay or disruption of the cell cycle
(86). Viability assays have shown that cell death occurs probably in a subset of cells
in a population (268). By observing telomere length dynamics over a time course, and
by measuring active ES telomere length in individual clones, we show that telomere
length is heterogenous at the active ES. This suggests that telomere length changes
(breakage?) still occurred in the absence of Mre11. Very preliminary results suggest
that Mre11 is not involved in telomere G-overhang maintenance and we speculate
that Mre11 does not play a role at T. brucei telomeres.
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Figure 51
Pulsed-Field Gel Electrophoresis Overhang Assay (PFGE-OH) in wild-type,
MRE11-, KU- and TERT-deficient T. brucei.
Upper panel: native PFGE were in-gel hybridized with C-rich and G-rich
telomere probes. G-overhang signal can be readily detected on highly
abundant minichromosomes (arrowhead).
Lower panel: Loading was verified by denturation and re-hybridization of
both gels with the same probes.Chromosome types are indicated on the right,
exposure times on the right.

Chapter VIII: Conclusions and perspectives
T. brucei survives in the mammalian host by sequential expression of subtelomeric
VSG genes. Numerous other parasites express variable surface antigens from
subtelomeric expression cassettes. What advantages does this location offer and do
telomeres play any role in regulating VSG expression?
By creating a telomerase-deficient cell line, I aimed to address these questions.
In this chapter, I will briefly review my results and focus on questions that I find
particularly fascinating and that I could not answer in the course of my thesis. Lastly,
I present a speculative model of how telomere length and breakage could regulate the
frequency of antigenic variation.

The length of T. brucei G-overhangs

T. brucei G-overhangs cannot be visualized by conventional in-gel hybridization,
whose detection limit is ~30 nt (109). When overhang assays were performed on
whole chromosomes, separated by PFGE, a G-strand specific signal was detected on
MC. We propose that this signal is due to the high abundance of MC, which migrate
together under the used separation condition, and does not reflect a difference in
telomere end structure between these chromosome types.
The rate of telomere shortening correlates with the length of the G-overhang (118). In
telomerase-deficient T. brucei, telomeres shorten at a rate of 3–6 bp/PD, which
suggests, that overhangs are very short (6–12 nt). This issue could be resolved in
detail by employing a recently established telomere-tailing and primer extensionbased protocol, which permits measurement of G-overhang length at nucleotide
resolution (120).

122

Telomere stabilization at silent ES

In chapter III, we demonstrated that critically short silent ES telomeres stabilized
within a distinct size range of 40–200 bp. Unfortunately, we can only speculate how
telomere stabilization is achieved. Due to the limited availability of drug selection
markers it remains a challenge to sequentially knock-out two genes in T. brucei. The
genetic requirements for telomere stabilization could be investigated by RNAi knockdown of certain candidate genes (such as Rad51, Mre11 etc.). We proposed that
telomere stabilization could be relevant for telomerase-deficient human ALT cells
and possibly budding yeast Type I survivors. This idea fascinates me very much, not
only because it would enhance the value of T. brucei as a model system for telomere
biologists, but also because of the implications it might have on telomerase-negative
tumor cells. A collaboration between laboratories interested in human ALT and T.
brucei could explore these possibilities in more detail.

What is the relevance of the slow migrating band in long-term cultured TERTdeficient T. brucei?

In extensively cultured telomerase deficient mutant strains, I noted the appearance of
a telomere repeat containing slow migrating band. The origins or relevance of this
band remains a mystery and it is unclear whether it plays a role in telomere
stabilization. I cannot exclude the possibility the high molecular band is indeed
circular, yet so large that it cannot be properly resolved even on a 2-D gel. On figure
19 as well as on other similar gels, the intensity of this band appeared to increase over
time. Although I did not succeed in identifying the origin or relevance of this band,
further propagation of the telomerase-deficient mutants might facilitate
characterization of the band.
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Is subtelomeric silencing impaired at short stabilized telomeres?

Telomere-associated factors are implicated in transcriptional silencing of
subtelomeric reporter genes in yeast: the Telomere Position Effect (TPE) (269). TPElike silencing occurs at silent ES in T. brucei (49). Does T. brucei TPE depend on
telomere-associated factors and would short stabilized telomeres still exert this effect
on subtelomeric region? Our results suggest that stabilization of a silent ES telomere
does not lead to transcriptional activation of its adjacent VSG, and the strain
continuous to express VSG 221. However, we do not know whether subtelomeric
silencing is perturbed. This question could be addressed in detail by inserting a
luciferase-reporter cassette at different positions within a silenced ES. Luciferase
levels would be indicative whether partial derepression of silencing occurs during
telomere stabilization.

A model for how telomere length and breakage could regulate antigenic variation

Chapters III and V covered the consequences of telomere shortening in the context of
silent and active ES. In the proposed model, telomere breakage at the active ES was
repaired by BIR, leading to a duplicative gene conversion event. In chapter IV,
telomere elongation dynamics at silent and active ES were addressed. In chapter VI,
we demonstrated that wild-type isolates have much shorter telomeres than laboratoryadapted strains. I discussed that wild-type T. brucei isolates have a high frequency of
antigenic switching (10-2–10-4), which is greatly reduced (10-6–10-7) after long-term
passaging in mice in the absence of immune selection (73,74,82,90,91).
I propose a speculative model, which is based on old data, experimental observations
using telomerase-deficient T. brucei, and the results presented in chapter VI. This
model proposes that telomere growth and breakage at the active ES could regulate the
rate of antigenic variation, and explains how propagation by syringe passaging that
avoids the immune response could reduce the switching frequency.
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In Figure 52, the X-axis represents the duration of laboratory propagation, in mice or
in culture, and the Y-axis represents the length of the active ES. The intersection
between X-and Y axis marks the border between subtelomeric region (below) and
telomeric repeats (above) and vertical bars represent the amount of DNA that could
be lost as a consequence of breakage. These truncations lead to deletion of
chromosome terminal regions and could be a consequence of having both replication
and transcription bubbles approaching the end. The amount of lost DNA could reflect
the distance from the chromosome end at which the replication fork stalls and gives
rise to a DSB. At an active ES with a short telomere, these DSB are more likely to fall
within the subtelomeric region. Breaks that fall within the telomere tract are rapidly
extended by telomerase (50,231). In wild-type African isolates with short telomeres,
detection of a DSB presumably triggers a cell cycle arrest and DNA repair through
BIR, as it does in other organisms. During BIR, the 3´ overhang could invade another
ES, where extension of the 3´ termini by DNA polymerase, and lagging strand
synthesis, would repair the break and give rise to an antigenic switch through
duplicative gene conversion. Both scenarios could lead to a slight growth
disadvantage, favoring parasites whose ES telomere did not break but continued
elongating. This rapid elongation, which is unique to short active ES telomeres,
would decrease the probability of a subsequent truncation falling within the
subtelomeric region, thereby reinforcing stable expression of a single VSG (Figure
52). Another consequence of stably transcribing a single ES is that all silent ES
telomeres will grow constantly, without being afflicted by truncations, in contrast to
what would happen if there was rapid in-situ switching among ES, which would
expose multiple ES to truncations and further accelerate VSG switching.
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Figure 52
Model for how telomere length and telomere breakage could regulate
the frequency of antigenic variation. X-axis represents time of laboratory
adaptation. Y-axis represents the length of the active VSG 221 ES.
Telomere and subtelomeric regions are separated by X-axis. Telomere
truncations are represented by shadowed vertical bars. Telomere
elongation dynamics at silent and active ES are indicated on the right,
consequences of telomere truncations on the far left.

In conclusion my model proposes that telomere length and stalled replication fork
induced DSB could regulate the frequency of antigenic switching. Consistent with
this model, deletion of Rad51—a homologue of bacterial RecA implicated in
homologous strand annealing during BIR—led to a ~10 fold decrease in switching
frequency (88). As discussed below, this model could also be applicable to the
regulation of antigenic switching in other bacterial and fungal pathogens that express
variant antigens from subtelomeric loci.

Telomere length homeostasis in wild-type isolates

As pointed out above, stable VSG expression and consequent telomere growth could
account for the telomere size differences observed between laboratory-adapted strains
and wild-type isolates, so how could telomere length homeostasis be achieved in
wild-type isolates? Considering the number of metacyclic and bloodstream form ES
in T. brucei, it is likely that most MBC arm is occupied by an ES.
In a natural infection, telomere length homeostasis could be achieved through in-situ
ES switches. Upon activation, these telomeres would suffer truncations that
counteract their constant growth. Maybe telomeres must reach a certain length before
transcriptional activation occurs, otherwise telomere truncations would eradicate the
new VSG too rapidly, exhausting the VSG repertoire too quickly and jeopardizing
long-term survival of the cell. Thus the dramatic truncations that occur at the active
ES explain the need for silent ES telomeres to elongate at a constant rate. The
telomere lengths of wild-type isolates would represent an equilibrium between
constant telomere growth at silent ES, rapid elongation at the active ES, telomere
truncations and antigenic switching.
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Implication for other parasites using antigenic variation

Borrelia burgdorferi, the causative agent of relapsing fever and lyme disease evades
the host immune response by sequentially expressing different Major Variable
Antigens (VMP). VMP are encoded by genes located at telomeres of linear plasmids.
VMP gene expression switching can occur via gene conversion at a rate of roughly
10-3–10-4 per cell generation (94,270,271). The surface of P. carinii, a fungus that
causes pneumonia in immune-compromised mammals, is covered with a dense coat
of Major Surface Glycoproteins (MSG), which play a role in mediating adherence to
alveolar epithelial cells (272). Indirect immunofluorescence studies showed that only
one particular MSG protein is expressed at a given time (93,273). The P. carinii
genome contains ~100 different MSG which reside at chromosome ends (93). It has
been proposed that switches occur through recombination where the single ES
associated MSG is replaced by a new MSG through gene conversion and that MSG
switching occurs at a high frequency of ~10-2 per cell division (273). However,
despite the similarity between these organisms, it remains to be determined whether
the telomere adjacent to the actively transcribed VMP or MSG is subject to frequent
breakage or growth.
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Chapter IX: Material and Methods
Trypanosome cell lines and plasmid constructions
T. brucei bloodstream forms, strain Lister 427 antigenic type MITat 1.2 clone 221a
(274,275), were cultured in HMI-9 at 37°C. This cell line, when engineered to
express T7 RNA polymerase, Tet repressor and neomycinphosphotransferase, was
designated the bloodstream-form ‘single marker’ line (259), and was cultured in
HMI-9 containing 2.5 µg/ml G418 (Sigma).
Homozygous TERT deletion mutants were generated by sequentially replacing the
two alleles with genes encoding resistance to 0.1 µg/ml Puromycin and 5 µg/ml
Hygromycin, by a double crossover event, using the TERT 5´ and 3´ untranslated
regions (UTR) as targeting sequences. The UTRs were amplified by PCR from
genomic DNA. NotI and PmeI sites (bold) were included to facilitate subsequent
cloning

steps:

5´

UTR

upper

primer;

G C G G C C G C AATGCTGTTTCTGTCTGCATAA: 5´ UTR lower primer;
G T T T A A A C GTAGTCGGCTGTCCAACGTTAG: 3´ UTR upper primer;
GTTTAAACAATGCAAGCTTTTCTCCTTCACGCG: 3´ UTR lower primer:
GCGGCCGCAATATAAGTAAGGGAAAGACA. PCR products were cloned into
pGEM-T easy (Promega), released by a NotI / PmeI digestion and ligated together
into NotI digested, alkaline phosphatase treated pBluescript II SK(+) (Stratagene)
creating Vector 2-4. The puromycin N-acetyltransferase ORF, flanked by ~100 bp of
5´ and 220 of 3´ UTRs from the T. brucei actin gene, was released from pHD309puro. The restriction fragment was blunt ended by DNA Pol I (large Klenow
fragment) and ligated into PmeI digested, dephosphorylated Vector 2-4 creating
Vector 2-4-Puro. The gene encoding hygromycin phosphotransferase, plus ~100 bp of
5´ and 300 bp of 3´ UTRs from the T. brucei actin gene, was released from pHD309hygro and ligated into PmeI-digested Vector 2-4 creating Vector 2-4-Hygro. Vectors
2-4-Puro and 2-4-Hygro were digested overnight with NotI, prior to transfection into
T. brucei single marker cell line as described previously (259).
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Alignment of telomerase reverse transcriptase sequences
TERT sequences from T. brucei, T. cruzi (GeneDB ID: Tc00.10470535097456) and
L. major (GeneDB ID: LmjF36.3930) were aligned with TERT characteristic motifs
from other organisms, using the ClustalX multiple sequence alignment function of
MegAlign software (DNAstar Inc.).
RNA isolation and VSG RT-PCR
T. brucei mRNA was isolated using RNAstat60 according to the protocol provided by
Tel-Test Inc. The dominant VSG in the population was cloned by reverse
transcriptase PCR using oligos against the conserved T. brucei spliced leader
sequence (5´-GACTAGTTTCTGTACTATAT-3´) and a VSG C-terminal conserved
region (5´-GACTAGTGTTAAAATATATCA-3´). Polymerase chain reaction was
carried out for 30 cycles under the following conditions: 1 minute at 94°C, 1 min at
40°C, 1 min at 72°C.
TERT N-terminal RT-PCR
mRNA was isolated as described above, cDNA was generated by using ProSTARTM
First-Strand RT-PCR Kit from Stratagene.
Forward Primer C: 5´-ACGACGCTGTGTCTGGTAAT-3´, was used in conjunction
with two different reverse primers: A: 5´-TTCGGAAGTCACACGCT-3´ or reverse
primer B: 5´-CGGGCTTTTAGAGGTA-3´ on genomic DNA and cDNA. PCR
conditions were as follows: initial denturation for 2 min at 94°C, then 28 cycles of 30
sec at 94°C, 30 sec at 50°C and 60 sec at 72°C. To detect small size changes, PCR
products were separated on a 1.8% agarose gel.
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Time course and telomere blots

Telomere length changes were analyzed by culturing parental cells in parallel with
heterozygous and homozygous telomerase deletion mutants. Every week, genomic
DNA was isolated as previously described (101). Genomic blotting and hybridization
was performed as described previously (276). Size changes in silent ES telomeres
were detected by digesting genomic DNA with the restriction enzymes indicated in
the figures. Terminal restriction fragments containing VSG genes were detected as
described by Horn et al. (82).

G-strand overhang assay

G-strand overhang assays were performed according to a published protocol (109)
with minor modifications. Gels were hybridized overnight at 30°C in Church Mix
(0.5 M NaPO4 pH 7.2, 1 mM EDTA pH 8.0, 7% SDS, 1% BSA). After washing 3
times for 30 min with 4 x SSC (1 x SSC is 15 mM tri-sodium citrate, 150 mM NaCl)
and once for 30 min with 4 x SSC + 0.1% SDS at 20°C, the gel was exposed to a
phosphorimager screen for at least 72 h. The gels were then denatured, neutralized,
and hybridized overnight with the same probes. After washing as described above but
at 55°C, the gel was exposed to a phosphorimager screen for 3–5 h.

T. brucei cell and HeLa genomic DNA mixing experiment
To determine whether T. brucei cell extracts might degrade G-strand overhangs, T.
brucei cells were centrifuged and washed twice in 1 x TDB (5 mM KCl, 80 mM
NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2 mM NaH2PO4, 20 mM glucose, pH 7.7)
then mixed with HeLa cell DNA at different ratios and DNA was re-isolated as
described above. G-overhang assay was performed as described above.
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Enzymatic modification of T.brucei DNA
DNA was incubated with 30 units of T7 (Gene 6) Exonuclease (US Biochemicals) for
20 min at 37°C or with 20 units of E.coli Exonuclease I (US Biochemicals) for 12 h
at 37°C (100,234). Overhang assay conditions were the same as above.

2-dimensional gel electrophoresis

MboI / AluI digested DNA of T. brucei TERT deficient mutant and human ALT cell
line Saos-2, kindly provided by Sean Rooney, de Lange laboratory (positive control)
were separated on 2 dimensional (2D) gel electrophoresis according to a protocol
from Fangman and Breyer (201). Both DNA were separated in the first dimension on
a large 400 ml 0.4% agarose in 1xTBE gel without ethidium bromide. The gel was
run at 18 volts for 24 hours at room temperature. The gel was stained for 20 minutes
in 1xTBE with 0.3 µg/ml Ethidium Bromide, migration was verified in the darkroom
using the handheld UV light stick at long wave length. Bands of positive control and
TERT deficient cell lines were excised from the gel, transferred to a second gel tray
and embedded perpendicular in 400ml 1.1% agarose in 1x TBE +0.3 µg/ml.
The gel was run at 150 volts at 4°C for approximately 7 hours. The gel was
photographed on the UV box, DNA was transferred to a membrane by Southern
blotting for subsequent hybridization. To visualize telomeric fragments, denaturing in
gel hybridization, using a radiolabeled (TTAGGG)4 probe gave better results (as
described for overhang assays).

Complementation of telomerase-deficient mutant strains

To complement the TERT deletion phenotype, the tbTERT open reading frame was
amplified using primers that introduce NdeI restriction sequences at 5´ and HpaI site
at the 3´ of the gene. The PCR product was cloned into pGEM-T easy (Promega) and
clones from independent PCR reactions were sequenced to exclude the possibility of
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PCR-derived mutations. To put the ORF under the control of an inducible T7
promoter, the 3.579 kB PCR product was released by NdeI / HpaI digestion and
cloned into NdeI / HpaI digested pCO-57; this step removes a GFP cassette from
pCO57, a derivative of pLew82 (259). Proper integration was verified by restriction
analysis and sequencing. To introduce a GFP tag at the telomerase C-terminus, NdeI
sites were introduced by PCR at both ends of the TERT orf, cloned into pGEM-T
easy, released and ligated into NdeI cut and dephosphorylated pCO57. The constructs
were linearized by digestion with NotI and transfected into telomerase-deficient cell
lines. Selection for integration positive clones was achieved by the addition of 2.5
µg/ml Phleomycin. Upon reintroduction, TERT expressing clones were verified by
Southern blot (data not shown) and maintained in continuous culture for several
weeks. DNA was extracted on a weekly basis and telomere length changes at
transcriptionally silent and active ES were monitored by Southern hybridization.
Expression of the fusion product was induced by addition of 100 ng / ml doxycycline.
To assess whether TERT-gfp is fully functional, its ability to elongate a short
telomere was compared with a re-introduced wildtype allele of telomerase as well as
an HA-tagged version of tbTERT. Wildtype and TERT-gfp constructs were fully
functional whereas HA-TERT did not elongate telomeres (data not shown).

Bal31 Digestions

Bal 31 digestion was performed as described previously (101). Briefly, 100 µg of
DNA in 500 µl volume were incubated at 30°C with 5 Units of Bal 31. At different
timepoints (15, 30, 50 and 120 minutes), a 100 µl sample was removed, added to 2 µl
0.5 M EGTA, incubated at 65°C for 10 minutes and stored at -20°C until DNA was
extracted by Phenol – Chloroform - Isoamyl-alcohol, precipitated and dissolved in
T10E0.1 (10 mM Tris pH 7.4, 0.1 mM EDTA) buffer. Subsequently, DNA was EcoRI
digested and loaded on a 0.8 % agarose gel. Southern blotting and hybridization
procedures were performed as described (265).
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Telomere tailing procedure and PCR amplification

These experiments were carried out as described before with minor modifications
(244). To increase the efficiency of telomere tailing, Terminal Restriction Fragments
(TRF) corresponding to the size of stabilized VSG 121 telomere (~1.6 kB), were
isolated from an 0.8% agarose gel. Approximately 100 ng of TRF in 1x one-phor-all
buffer (Pharmacia), 1mΜ dCTP and 5 U of terminal deoxynucleotidyl transferase
(Amersham Biosciences) were incubated for 30 minutes at 37°C. The efficiency of
the tailing reaction was verified by addition of radiolabeled dCTP to the reaction mix
and running the products on agarose gels (data not shown).
The tailing reactions were PCR amplified using 0.75 µM primer A (5’ACACAGGCGAACCAGAATGACGCTGCAGCCAAAGCA-3’), 1.0 µM primer B
(CCCCC)3, 320 µM dNTPs, 10x TAQ polymerase buffer and 2.5 U of TAQ
polymerase by incubating for 2 min at 94°C, followed by 45 cycles of 45 seconds at
94°C, 45 seconds at 65°C and 70 seconds at 72°C. PCR amplified products were
separated on a 1.2% agarose gel and non-tailed TRFs were amplified in parallel as
negative control. Specific products were gel purified and sucloned into pGEM-T
(Promega). Restriction digests were performed as described by manufacturers
directions (New England Biolabs). Sequencing reactions were carried out by
GeneWiz Inc (North Brunswick, NJ).

Rotating agarose gel electrophoresis

DNA agarose plugs were prepared as described by Navarro and Cross (55). Briefly, 2
x 108 cells were harvested, washed in Trypanosome Dilution Buffer (TDB),
resuspended in 0.5 ml L-Buffer (0.1 M EDTA pH 8.0, 10 mM Tris-HCl pH 7.6, 20
mM NaCl) and incubated for 10 minutes at 42°C. 0.5 ml of 1.6% low gelling agarose
(Sigma) in L-Buffer was added to 0.5 ml cells, mixed and poured into Plug Molds
(Bio-Rad Laboratories). Plugs were treated in 3 ml L-Buffer for 2 days with 1 mg/ml
proteinase K at 50°C. Upon washing twice for 15 minutes with L-Buffer, proteinase
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K treatment and washing was repeated. Plugs were embedded in 0.8% Agarose in 0.5
x Tris-borate-EDTA gel. Megabase (MBC), intermediate (IC) and minichromosomes
(MC) were separated under conditions previously described by Navarro and Cross
(23). 1st window; linear ramp 100 - 300 seconds for 10 hours at 120 volts, 2nd
window; 1000 – 2500 seconds for 80 hours at 50 volts. Gels were dried at room
temperature and hybridized as described above. Separation of MC and IC took place
at a rotation angle of 120° in 0.5x Tris-borate-EDTA at 12°C. The program consisted
of one ramped pulse time of 60-s to 20-s at a constant voltage of 110 V for 60 h
(Luisa Figueiredo, unpublished data). For in-gel hybridization with radiolabeled
telomeric oligonucleotides, gels were dried at room temperature, denatured and
neutralized; in-gel hybridization was performed as described previously (265). DNA
was blotted onto a Hybond membrane, cross-linked in a UV-stratalinker 1800
(Stratagene), hybridized and washed as described. Signals were quantified using a
phosphorimager screen and ImageQuant software (Molecular Dynamics).
To quantify the extent of MC loss, PFGE gels were run in duplicates: Gel 1 was ingel hybridized using a radiolabelled (TTAGGG)4 probe whereas Gel 2 was blotted
onto Hybond N+ membrane and sequentially probed with 50-bp repeats, 177-bp
repeat and individual VSG probes. MC 177 and 50-bp probes were obtained by PCR
amplification from genomic DNA as previously described (246). Hybridized
membranes were exposed to phosphorimager screens and signal intensity of
individual bands was quantified using ImageQuant software.

To analyze the

reduction in MC 177-bp signal, 50-bp repeat and VSG probes were used to normalize
loading.

Slot Blot hybridization

0.4 to 0.8 µg of DNA from wild-type and long term cultured TERT deficient strains
was added to 6 x SSC (900 mM NaCl, 90 mM sodium citrate, pH 7.0), boiled for 10
minutes and placed on ice. 200 and 400 µl of denatured DNA were applied to
manifold device containing a 6 x SSC equilibrated Hybond N+ membrane. By
applying suction, the DNA was applied in duplicates onto the membrane. Upon
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dismantling the apparatus, the membrane was cross-linked and hybridized with 177bp and 50-bp repeat probes. Signal intensities were quantified using Phosphorimager
screens (Molecular Dynamics).

Telomere size distribution analysis

Terminal restriction fragments containing specific VSG were detected by genomic
blotting, hybridization and phosphorimaging (49). Using Image Quant software, all
lanes were partitioned into 30 equally sized rectangles. The signal intensity in each
rectangle was measured as a percentage of the total signal in the entire lane and
graphically represented as a function of telomere length.

Long-range Southern blot

Digestion of DNA in genomic plugs was performed as recommended by the enzyme
manufacturer (New England Biolabs). 60 Units of ApaI were incubated in NEB
buffer 4 + 1x bovine serum albumin at 25°C overnight. Plugs were subsequently
washed in TE (0.1 M EDTA pH 8.0, 10 mM Tris-HCl pH 7.6). Restriction fragments
were separated on a 0.8% agarose gel in 0.5x TBE. We used a program consisting of
a 1–12 sec linear ramp at a constant 150 v for 15 h at 12°C. The rotation angle was
120°.

Northern Blots and RT-PCR

T. brucei mRNA was isolated using RNAstat60, according to the manufacturer’s
protocol. The dominant VSG expressed by the population was cloned by RT-PCR
using oligos against the conserved T. brucei spliced leader sequence (5´GACTAGTTTCTGTACTATAT-3´ and a VSG C-terminal conserved region 5´GACTAGTGTTAAAATATATCA-3´. Polymerase chain reaction was carried out for
30 cycles of 1 min at 94°C, 1 min at 40°C, 1 min at 72°C.
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History of T. brucei strains

The detailed lineages of T. brucei cell lines used in these studies and by other
laboratories are available at http://tryps.rockefeller.edu/trypanosome_pedigrees.html.
The strain abbreviations used in this paper are indicated in parentheses.
T. brucei S42, 348 and T. b. rhodesiense s427 are isolates that have not been adapted
for virulent growth. S42 (S42) was isolated from a female warthog, near Kirawira,
Tanzania, on March 1966 (277). It was minimally passaged before being transmitted
through tsetse in November 1974. STIB366D was derived from a single metacyclic
cell and was minimally propagated before freezing as RUMP102, which we used as
our source of S42 DNA. 246/STIB348U/MIAG106 (348) was isolated from a
Hartebeest in Serengeti in 1971 (278). After growth in mice and rats for a total of ~6
weeks, it was transmitted through tsetse in July 1975. STIB348U was derived from a
single metacyclic cell, and frozen as MIAG106 (our source of DNA) after passage
through 2 irradiated mice. T. b. rhodesiense RUMP151 (151) is derived from the true
s427, which was isolated in 1960 from a sheep in south-east Uganda (279). s427 was
passaged through ~20 mice before being frozen as RUMP151, which is highly
resistant to human serum (GAMC, unpublished data), consistent with its isolation
from an area of epidemic human sleeping sickness ((279) and M.P. Cunningham,
personal communication).
TREU927 (TREU927) was isolated in Kiboko, Kenya in 1969 or 1970, and preserved
after 3–11 passages (280). The procyclic cells from which we isolated DNA had been
propagated for at least thirty 2–3 day transfers in mice (92), before being
differentiated to procyclic forms in the laboratory of Scott Landfear and further
propagated for about 75 PD.
The origin of Lister 427 (427) is unknown. It is not related to s427, as originally
thought, and was maintained by syringe passage during indeterminate intervals from
1961–1967. Lister 427 ‘single-marker’ (SM) (259) bloodstream and 29-13 procyclic
forms are extensively propagated laboratory-adapted clones with a low switching
frequency of ~10-6–10-7 / PD (74,82). The relative positions of RUMP150 and
RUMP501 in the Lister 427 lineage are clear, and their genotypic identity has been
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verified on several occasions (C.M.R. Turner and G.A.M. Cross, unpublished data).
RUMP150 is genetically indistinguishable from single-marker bloodstream and 29-13
procyclic clones, but the degree of propagation of Lister 427 prior to its preservation
as RUMP501 cannot be verified.
RUMP100 and RUMP502 are descendants of EATRO795, isolated from a Zebu cow
in Kenya (Sept. 8th, 1964) (73,90,91,281), which has a high switching frequency. The
ancestors of RUMP100 (100) were recloned several times, with minimal passaging,
prior to infecting a mouse with a single metacyclic, yielding STIB367H, from which
the RUMP100 population was frozen after one additional mouse passage. RUMP502
(502) is one passage removed from GUP2900 (GUG359). Although we lack
documentation of the lineage prior to GUP2900, RUMP502 was recently verified to
be genetically indistinguishable from EATRO795 (C. M. R. Turner, personal
communication). DNA samples from paired samples of two other strains, before and
after laboratory-adaptation, were kindly provided by C. M. R. Turner (Glasgow
University). STIB247 (247) was isolated during the same expedition as STIB246/348
(see above) and probably also frozen after ~6 weeks of growth in mice and rats (278).
Cloning of the population led to STIB247L (282) and 52 2-3 days syringe passages
yielded GUTat 8.1 (283). Strain 386 (386) was isolated from a patient on the Ivory
Coast in 1978 by members of the Bernhard-Nocht Institute, Hamburg (284). The
detailed events between isolation and cloning of STIB386AA are unclear. DNA we
obtained was before and after 52 passages in mice that led to dominant expression of
GUTat 9.1 (283).

Cultivation of African wild-type strain isolates of T. brucei

African isolates strains were first grown in female CD-1 AKA ICR (Charles River)
mice. After 3 days, approximately 108 cells were harvested from anesthetized mice by
heart puncture and grown for 3 days in male Sprague Dawley rats (Charles River).
Laboratory-adapted Lister 427 derivatives were cultured in HMI-9 at 37°C (274,275).
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Cultivation of Leishmania and T. cruzi

Leishmania major Friedlin strain was cultured in M199 (GIBCO) plus supplements
(40 mM HEPES, pH 7.4; 0.1 mM adenine; 1 µg/ml biotin; 5 µg/ml hemin; 1x Penstrep (GIBCO); 10% bovine calf serum). L. tarentolae isolates were grown in brainheart infusion medium (DIFCO) plus 10 mg/l hemin. A clone of T. cruzi Y strain
epimastigotes containing FLAG-tagged gp72 (285) was grown in LDTN medium
(286).
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